J. A. Perea Egido

J. A. Perea Egido's AcademicInfluence.com Rankings

J. A. Perea Egido

Philosophy

#4305

World Rank

#6776

Historical Rank

Logic

#1798

World Rank

#2640

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is J. A. Perea Egido Influential?

(Suggest an Edit or Addition)

(See a Problem?)

J. A. Perea Egido's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Inflammation and angiotensin II. (2003) (661)
Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. (1997) (548)
Angiotensin II and renal fibrosis. (2001) (481)
HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis. (1998) (458)
Transcription factor-kappa B (NF-kappa B) and renal disease. (2001) (434)
TGF-β signaling in vascular fibrosis (2007) (426)
NF-kappaB in renal inflammation. (2010) (414)
3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture. (1998) (412)
Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. (2002) (411)
Proinflammatory actions of angiotensins (2001) (401)
NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy. (2004) (368)
Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells. (1999) (361)
Biochemical and functional characterization of the interaction between pentraxin 3 and C1q (2003) (348)
Animal Models of Cardiovascular Diseases (2011) (339)
Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms. (2000) (335)
Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. (2006) (331)
Anti-inflammatory and immunomodulatory effects of statins. (2003) (323)
Glucosamine inhibits IL-1β-induced NFκB activation in human osteoarthritic chondrocytes (2003) (321)
Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans (2010) (320)
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial (2019) (306)
Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis. (1998) (305)
Role of the renin-angiotensin system in vascular diseases: expanding the field. (2001) (302)
The inflammatory cytokines TWEAK and TNFα reduce renal klotho expression through NFκB. (2011) (302)
Angiotensin II Activates the Smad Pathway in Vascular Smooth Muscle Cells by a Transforming Growth Factor-β–Independent Mechanism (2005) (298)
TGF-beta signaling in vascular fibrosis. (2007) (290)
Tenofovir Nephrotoxicity: 2011 Update (2011) (278)
Ferroptosis, but Not Necroptosis, Is Important in Nephrotoxic Folic Acid-Induced AKI. (2017) (271)
Connective Tissue Growth Factor Is a Mediator of Angiotensin II–Induced Fibrosis (2003) (249)
Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. (2001) (236)
Identification by a Differential Proteomic Approach of Heat Shock Protein 27 as a Potential Marker of Atherosclerosis (2004) (229)
Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. (2004) (226)
Mechanisms of renal apoptosis in health and disease. (2008) (219)
Vasoactive hormones and renal sclerosis. (1996) (218)
Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts. (1997) (214)
Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart. (1993) (212)
3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation. (2002) (207)
High concentration of branched‐chain amino acids promotes oxidative stress, inflammation and migration of human peripheral blood mononuclear cells via mTORC1 activation (2017) (203)
Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. (2003) (199)
Systemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptors. (2001) (194)
Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes. (2003) (182)
Olive oil and walnut breakfasts reduce the postprandial inflammatory response in mononuclear cells compared with a butter breakfast in healthy men. (2009) (179)
Globotriaosylsphingosine actions on human glomerular podocytes: implications for Fabry nephropathy. (2011) (179)
Novel methodologies for biomarker discovery in atherosclerosis. (2015) (176)
The cytokine TWEAK modulates renal tubulointerstitial inflammation. (2008) (170)
Interaction of IgA with Fc alpha receptors of human mesangial cells activates transcription factor nuclear factor-kappa B and induces expression and synthesis of monocyte chemoattractant protein-1, IL-8, and IFN-inducible protein 10. (1997) (168)
Red Wine Intake Prevents Nuclear Factor-&kgr;B Activation in Peripheral Blood Mononuclear Cells of Healthy Volunteers During Postprandial Lipemia (2000) (168)
Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition. (2001) (167)
Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth. (1996) (167)
Suppressors of cytokine signaling abrogate diabetic nephropathy. (2010) (165)
Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-alpha and IL-6, and proliferation. (1994) (165)
Molecular mechanisms of angiotensin II-induced vascular injury (2003) (163)
Renal and vascular hypertension-induced inflammation: role of angiotensin II (2006) (163)
Tubular NF-κB and AP-1 activation in human proteinuric renal disease (2001) (162)
Unilateral ureteral obstruction: beyond obstruction (2014) (159)
Activation of NF-&kgr;B in Tubular Epithelial Cells of Rats With Intense Proteinuria: Role of Angiotensin II and Endothelin-1 (2001) (157)
Potential Role of Nuclear Factor κB in Diabetic Cardiomyopathy (2011) (157)
Implementation of proteomic biomarkers: making it work (2012) (155)
Butter and walnuts, but not olive oil, elicit postprandial activation of nuclear transcription factor kappaB in peripheral blood mononuclear cells from healthy men. (2004) (152)
Paracetamol-induced renal tubular injury: a role for ER stress. (2004) (150)
Diagnostic approaches for diabetic cardiomyopathy (2017) (149)
Therapeutic approaches to diabetic nephropathy—beyond the RAS (2014) (148)
High-resolution MRI detects cartilage swelling at the early stages of experimental osteoarthritis. (2001) (147)
The CD163-expressing macrophages recognize and internalize TWEAK: potential consequences in atherosclerosis. (2009) (147)
Cytokine cooperation in renal tubular cell injury: the role of TWEAK. (2006) (147)
Prevalence of fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy. (2007) (144)
Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy. (2000) (139)
Intracellular mechanisms of cyclosporin A-induced tubular cell apoptosis. (2003) (138)
ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis. (1998) (137)
Vascular actions of synthetic PAF-acether (a synthetic platelet-activating factor) in the rat: evidence for a platelet independent mechanism. (1982) (136)
Angiotensin III increases MCP-1 and activates NF-kappaB and AP-1 in cultured mesangial and mononuclear cells. (2000) (132)
Molecular Mechanisms and Novel Therapeutic Approaches to Rhabdomyolysis-Induced Acute Kidney Injury (2015) (131)
Angiotensin-(1–7) and the G Protein-Coupled Receptor Mas Are Key Players in Renal Inflammation (2009) (129)
Identification of Soluble Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (sTWEAK) as a Possible Biomarker of Subclinical Atherosclerosis (2007) (129)
Expression of apoptosis regulatory proteins in tubular epithelium stressed in culture or following acute renal failure. (2000) (127)
Prevalence of Fabry Disease in a Cohort of 508 Unrelated Patients With Hypertrophic Cardiomyopathy (2007) (125)
ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis. (1995) (125)
Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes (2017) (124)
Suppressors of Cytokine Signaling Modulate JAK/STAT-Mediated Cell Responses During Atherosclerosis (2009) (124)
Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation. (2008) (124)
Galectin‐3, a Biomarker Linking Oxidative Stress and Inflammation With the Clinical Outcomes of Patients With Atherothrombosis (2014) (121)
Nuclear factor-kappa B inhibitors as potential novel anti-inflammatory agents for the treatment of immune glomerulonephritis. (2002) (120)
Leukotriene B4 enhances the activity of nuclear factor-kappaB pathway through BLT1 and BLT2 receptors in atherosclerosis. (2009) (118)
Histopathological correlation of cartilage swelling detected by magnetic resonance imaging in early experimental osteoarthritis. (2004) (118)
2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications (2017) (118)
The expanding spectrum of biological actions of vitamin D. (2010) (118)
Endothelin-1, via ETA Receptor and Independently of Transforming Growth Factor-&bgr;, Increases the Connective Tissue Growth Factor in Vascular Smooth Muscle Cells (2005) (117)
Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells. (2002) (117)
Proapoptotic Fas ligand is expressed by normal kidney tubular epithelium and injured glomeruli. (2000) (116)
Regulation of Fas and Fas ligand expression in cultured murine renal cells and in the kidney during endotoxemia. (1996) (115)
Angiotensin II increases connective tissue growth factor in the kidney. (2003) (115)
Additive effects of soluble TWEAK and inflammation on mortality in hemodialysis patients. (2009) (115)
Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis. (2010) (114)
Targeting inflammation in diabetic nephropathy: a tale of hope (2018) (113)
CTGF promotes inflammatory cell infiltration of the renal interstitium by activating NF-kappaB. (2009) (113)
IgA glomerulonephritis (Berger's disease): evidence of high serum levels of polymeric IgA. (1980) (113)
Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats. (1994) (112)
Proteomic analysis of human vessels: Application to atherosclerotic plaques (2003) (111)
Atorvastatin Prevents Angiotensin II–Induced Vascular Remodeling and Oxidative Stress (2009) (111)
AKI associated with macroscopic glomerular hematuria: clinical and pathophysiologic consequences. (2012) (111)
Angiotensin-converting enzyme is upregulated in the proximal tubules of rats with intense proteinuria. (1999) (108)
Involvement of angiotensin II and endothelin in matrix protein production and renal sclerosis (1994) (108)
Curcumin reduces renal damage associated with rhabdomyolysis by decreasing ferroptosis‐mediated cell death (2019) (108)
The death ligand TRAIL in diabetic nephropathy. (2008) (106)
Intensive Treatment With Atorvastatin Reduces Inflammation in Mononuclear Cells and Human Atherosclerotic Lesions in One Month (2005) (106)
Rituximab treatment of adult patients with steroid-resistant focal segmental glomerulosclerosis. (2009) (105)
Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities (2020) (105)
High plasma levels of endothelin-1 and atrial natriuretic peptide in patients with acute ischemic stroke. (1994) (105)
TRPC6 mutational analysis in a large cohort of patients with focal segmental glomerulosclerosis. (2009) (104)
Fn14 Is Upregulated in Cytokine-Stimulated Vascular Smooth Muscle Cells and Is Expressed in Human Carotid Atherosclerotic Plaques: Modulation by Atorvastatin (2006) (104)
Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes. (2009) (103)
The MIF receptor CD74 in diabetic podocyte injury. (2009) (103)
HMG-CoA Reductase Inhibitors Decrease Angiotensin II–Induced Vascular Fibrosis: Role of RhoA/ROCK and MAPK Pathways (2007) (101)
Evidence for a specific IgA receptor in rat and human mesangial cells. (1993) (101)
Quest for novel cardiovascular biomarkers by proteomic analysis. (2005) (100)
Tubular NF-kappaB and AP-1 activation in human proteinuric renal disease. (2001) (100)
Angiotensin II activates nuclear transcription factor-kappaB in aorta of normal rats and in vascular smooth muscle cells of AT1 knockout mice. (2001) (99)
TWEAK Activates the Non-Canonical NFκB Pathway in Murine Renal Tubular Cells: Modulation of CCL21 (2010) (99)
Klotho, phosphate and inflammation/ageing in chronic kidney disease. (2012) (98)
The chronic intake of a Mediterranean diet enriched in virgin olive oil, decreases nuclear transcription factor kappaB activation in peripheral blood mononuclear cells from healthy men. (2007) (97)
Platelet-activating factor in anaphylaxis and phagocytosis. I. Release from human peripheral polymorphonuclears and monocytes during the stimulation by ionophore A23187 and phagocytosis but not from degranulating basophils. (1980) (96)
Parthenolide Modulates the NF-&kgr;B–Mediated Inflammatory Responses in Experimental Atherosclerosis (2006) (95)
TWEAK and RIPK1 mediate a second wave of cell death during AKI (2018) (95)
Tubular Cell Apoptosis and Cidofovir-Induced Acute Renal Failure (2005) (94)
Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver. (2009) (93)
Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy (2020) (92)
Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenac (2006) (92)
Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes. (2011) (92)
Tumor Necrosis Factor–Like Weak Inducer of Apoptosis (TWEAK) Enhances Vascular and Renal Damage Induced by Hyperlipidemic Diet in ApoE-Knockout Mice (2009) (91)
Plasma fingerprinting with GC-MS in acute coronary syndrome (2009) (91)
Angiotensin IV Activates the Nuclear Transcription Factor-&kgr;B and Related Proinflammatory Genes in Vascular Smooth Muscle Cells (2005) (90)
Soluble TWEAK plasma levels as a novel biomarker of endothelial function in patients with chronic kidney disease. (2009) (90)
TNF-related weak inducer of apoptosis (TWEAK) promotes kidney fibrosis and Ras-dependent proliferation of cultured renal fibroblast. (2013) (89)
TNF Superfamily: A Growing Saga of Kidney Injury Modulators (2010) (89)
Simvastatin reduces NF-kappaB activity in peripheral mononuclear and in plaque cells of rabbit atheroma more markedly than lipid lowering diet. (2003) (89)
3,4-Dideoxyglucosone-3-ene induces apoptosis in renal tubular epithelial cells. (2005) (88)
NF-&kgr;B Activation and Fas Ligand Overexpression in Blood and Plaques of Patients With Carotid Atherosclerosis: Potential Implication in Plaque Instability (2004) (88)
TWEAK and the progression of renal disease: clinical translation. (2014) (88)
Biological Significance of Decreased HSP27 in Human Atherosclerosis (2006) (87)
The inflammatory cytokine TWEAK decreases PGC-1α expression and mitochondrial function in acute kidney injury. (2015) (87)
Fc&ggr; Receptor Deficiency Confers Protection Against Atherosclerosis in Apolipoprotein E Knockout Mice (2006) (87)
Overexpression of COX-2, Prostaglandin E synthase-1 and prostaglandin E receptors in blood mononuclear cells and plaque of patients with carotid atherosclerosis: regulation by nuclear factor-kappaB. (2006) (86)
Statins: Could an old friend help in the fight against COVID‐19? (2020) (85)
Histone lysine crotonylation during acute kidney injury in mice (2016) (85)
Proteomic Analysis of Polymorphonuclear Neutrophils Identifies Catalase as a Novel Biomarker of Abdominal Aortic Aneurysm: Potential Implication of Oxidative Stress in Abdominal Aortic Aneurysm Progression (2011) (84)
Inflammatory biomarkers in stable atherosclerosis. (2006) (84)
Activation of Toll-Like Receptors and Inflammasome Complexes in the Diabetic Cardiomyopathy-Associated Inflammation (2014) (83)
Tweak induces proliferation in renal tubular epithelium: a role in uninephrectomy induced renal hyperplasia (2009) (82)
Increase of tumour necrosis factor α synthesis and gene expression in peripheral blood mononuclear cells of children with idiopathic nephrotic syndrome (1994) (82)
BASP1 promotes apoptosis in diabetic nephropathy. (2010) (82)
Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: a substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration. (2007) (81)
Cyclosporine A induces apoptosis in murine tubular epithelial cells: role of caspases. (1998) (81)
Possible Role of Parathyroid Hormone–Related Protein as a Proinflammatory Cytokine in Atherosclerosis (2003) (81)
Renal expression of angiotensin type 2 (AT2) receptors during kidney damage. (2003) (81)
Calcineurin inhibitors cyclosporine A and tacrolimus induce vascular inflammation and endothelial activation through TLR4 signaling (2016) (79)
An orally active ETA/ETB receptor antagonist ameliorates proteinuria and glomerular lesions in rats with proliferative nephritis. (1996) (79)
Sitagliptin Reduces Cardiac Apoptosis, Hypertrophy and Fibrosis Primarily by Insulin-Dependent Mechanisms in Experimental type-II Diabetes. Potential Roles of GLP-1 Isoforms (2013) (79)
Identification of Peroxiredoxin-1 as a Novel Biomarker of Abdominal Aortic Aneurysm (2011) (79)
The alpha-galactosidase A p.Arg118Cys variant does not cause a Fabry disease phenotype: data from individual patients and family studies. (2015) (77)
Predictive and diagnostic biomarkers for gestational diabetes and its associated metabolic and cardiovascular diseases (2019) (77)
Vitamin D receptor activation and cardiovascular disease. (2012) (76)
Aggregation of human polymorphonuclear leukocytes by endothelin: role of platelet-activating factor. (1992) (76)
The regulation of the inflammatory response through nuclear factor-kappab pathway by angiotensin IV extends the role of the renin angiotensin system in cardiovascular diseases. (2007) (76)
Peripheral Artery Disease Is Associated With a High CD163/TWEAK Plasma Ratio (2010) (75)
Involvement of tumor necrosis factor-alpha in the pathogenesis of experimental and human glomerulonephritis. (1995) (75)
Haematuria: the forgotten CKD factor? (2012) (74)
Licofelone, a Balanced Inhibitor of Cyclooxygenase and 5-Lipoxygenase, Reduces Inflammation in a Rabbit Model of Atherosclerosis (2007) (73)
Immunological abnormalities in the tonsils of patients with IgA nephropathy: inversion in the ratio of IgA: IgG bearing lymphocytes and increased polymeric IgA synthesis. (1984) (73)
Combined therapy with renin-angiotensin system and calcium channel blockers in type 2 diabetic hypertensive patients with proteinuria: effects on soluble TWEAK, PTX3, and flow-mediated dilation. (2010) (73)
Improving metabolite knowledge in stable atherosclerosis patients by association and correlation of GC-MS and 1H NMR fingerprints. (2009) (72)
Effect of simultaneous blockade of AT1 and AT2 receptors on the NFkappaB pathway and renal inflammatory response. (2003) (72)
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy. (2020) (72)
p-cresyl sulphate has pro-inflammatory and cytotoxic actions on human proximal tubular epithelial cells. (2014) (72)
Mesangial cells and glomerular inflammation: from the pathogenesis to novel therapeutic approaches. (2005) (71)
The Fas ligand/Fas system in renal injury. (1999) (70)
IL-17A is a novel player in dialysis-induced peritoneal damage. (2014) (70)
Targeting apoptosis in acute tubular injury. (2003) (69)
Pharmacological Modulation of Epithelial Mesenchymal Transition Caused by Angiotensin II. Role of ROCK and MAPK Pathways (2008) (69)
Phosphate: a stealthier killer than previously thought? (2012) (69)
Detection of monomeric and polymeric IgA containing immune complexes in serum and kidney from patients with alcoholic liver disease. (1982) (68)
TWEAK (tumor necrosis factor-like weak inducer of apoptosis) activates CXCL16 expression during renal tubulointerstitial inflammation. (2012) (68)
In situ non-radioactive detection of nuclear factors in paraffin sections by Southwestern histochemistry. (1999) (68)
Diagnostic and therapeutic strategies for small abdominal aortic aneurysms (2011) (68)
Branched‐chain amino acids promote endothelial dysfunction through increased reactive oxygen species generation and inflammation (2018) (68)
Contribution of apoptotic cell death to renal injury (2001) (67)
HSP90 inhibition by 17-DMAG attenuates oxidative stress in experimental atherosclerosis. (2012) (67)
3,4-di-deoxyglucosone-3-ene promotes leukocyte apoptosis. (2005) (67)
Alteration of Energy Substrates and ROS Production in Diabetic Cardiomyopathy (2013) (66)
Expression of IP-10, a lipopolysaccharide- and interferon-gamma-inducible protein, in murine mesangial cells in culture. (1993) (65)
Usefulness of a combination of monocyte chemoattractant protein-1, galectin-3, and N-terminal probrain natriuretic peptide to predict cardiovascular events in patients with coronary artery disease. (2014) (65)
Phosphorus and Nutrition in Chronic Kidney Disease (2012) (65)
Prevalence of protein-energy wasting syndrome and its association with mortality in haemodialysis patients in a centre in Spain. (2013) (64)
Renal diseases. (2020) (63)
Updating Experimental Models of Diabetic Cardiomyopathy (2015) (63)
Role of tumor necrosis factor-alpha in the pathogenesis of glomerular diseases. (1993) (63)
Expression of gremlin, a bone morphogenetic protein antagonist, in glomerular crescents of pauci-immune glomerulonephritis. (2007) (63)
Aldosterone Induces Renal Fibrosis and Inflammatory M1-Macrophage Subtype via Mineralocorticoid Receptor in Rats (2016) (63)
Bisphenol A in Chronic Kidney Disease (2013) (62)
Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes (2013) (62)
TLR4-mediated inflammation is a key pathogenic event leading to kidney damage and fibrosis in cyclosporine nephrotoxicity (2017) (62)
Anti-Fas antibodies induce cytolysis and apoptosis in cultured human mesangial cells. (1996) (62)
Persistent proteinuria up-regulates angiotensin II type 2 receptor and induces apoptosis in proximal tubular cells. (2004) (62)
HSP27/HSPB1 as an adaptive podocyte antiapoptotic protein activated by high glucose and angiotensin II (2012) (61)
Metabolomics with LC-QTOF-MS Permits the Prediction of Disease Stage in Aortic Abdominal Aneurysm Based on Plasma Metabolic Fingerprint (2012) (61)
Gremlin: a novel mediator of epithelial mesenchymal transition and fibrosis in chronic allograft nephropathy. (2008) (61)
Low plasma levels of HSP70 in patients with carotid atherosclerosis are associated with increased levels of proteolytic markers of neutrophil activation. (2007) (60)
The central role of nuclear factor-κB in mesangial cell activation (1999) (60)
Statins Inhibit Angiotensin II/Smad Pathway and Related Vascular Fibrosis, by a TGF-β-Independent Process (2010) (60)
3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Decrease Fas Ligand Expression and Cytotoxicity in Activated Human T Lymphocytes (2003) (60)
Immune complexes in IgA nephropathy: presence of antibodies against diet antigens and delayed clearance of specific polymeric IgA immune complexes. (1983) (60)
Angiotensin II: a double-edged sword in inflammation. (2000) (59)
Connective tissue growth factor is a new ligand of epidermal growth factor receptor. (2013) (59)
Increased Soluble Fas Plasma Levels in Subjects at High Cardiovascular Risk: Atorvastatin on Inflammatory Markers (AIM) Study, a Substudy of ACTFAST (2007) (59)
Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension. (2005) (59)
Erythrocytes, leukocytes and platelets as a source of oxidative stress in chronic vascular diseases: Detoxifying mechanisms and potential therapeutic options (2012) (59)
Expression of leucocyte chemoattractants by interstitial renal fibroblasts: up‐regulation by drugs associated with interstitial fibrosis (1996) (59)
Angiotensin II increases parathyroid hormone-related protein (PTHrP) and the type 1 PTH/PTHrP receptor in the kidney. (2002) (58)
Renal angiotensin II up-regulation and myofibroblast activation in human membranous nephropathy. (2003) (58)
Cytokines and Fas regulate apoptosis in murine renal interstitial fibroblasts. (1997) (58)
Targeting HSP90 Ameliorates Nephropathy and Atherosclerosis Through Suppression of NF-κB and STAT Signaling Pathways in Diabetic Mice (2015) (58)
Acceleration of neutrophil apoptosis by glucose-containing peritoneal dialysis solutions: role of caspases. (2001) (58)
Increased CD74 expression in human atherosclerotic plaques: contribution to inflammatory responses in vascular cells. (2009) (58)
The Rho-kinase pathway regulates angiotensin II-induced renal damage. (2005) (57)
Essential Role of TGF-β/Smad Pathway on Statin Dependent Vascular Smooth Muscle Cell Regulation (2008) (57)
Receptors for immune complexes activate gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: role of TGF-beta. (1996) (57)
Agonistic anti-Fas antibodies induce glomerular cell apoptosis in mice in vivo. (1997) (57)
Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy (2015) (57)
Increased plasma levels of NGAL, a marker of neutrophil activation, in patients with abdominal aortic aneurysm. (2012) (56)
Antioxidants in Kidney Diseases: The Impact of Bardoxolone Methyl (2012) (56)
Inhibitory effect of interleukin-1beta on angiotensin II-induced connective tissue growth factor and type IV collagen production in cultured mesangial cells. (2008) (56)
Considering TWEAK as a target for therapy in renal and vascular injury. (2009) (55)
Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade (2015) (55)
The Choice of Hemodialysis Membrane Affects Bisphenol A Levels in Blood. (2016) (55)
Angiotensin II regulates vascular endothelial growth factor via hypoxia-inducible factor-1alpha induction and redox mechanisms in the kidney. (2005) (55)
Long-term effect of nonsteroidal anti-inflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritis (1994) (55)
Lipid cartography of atherosclerotic plaque by cluster-TOF-SIMS imaging. (2007) (55)
Reduced sTWEAK and Increased sCD163 Levels in HIV-Infected Patients: Modulation by Antiretroviral Treatment, HIV Replication and HCV Co-Infection (2014) (54)
Fcgamma receptor deficiency confers protection against atherosclerosis in apolipoprotein E knockout mice. (2006) (54)
The Coming Age of Flavonoids in the Treatment of Diabetic Complications (2020) (53)
Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis (2008) (53)
Gremlin regulates renal inflammation via the vascular endothelial growth factor receptor 2 pathway (2015) (53)
Local Non-Esterified Fatty Acids Correlate With Inflammation in Atheroma Plaques of Patients With Type 2 Diabetes (2010) (53)
Targeted gold-coated iron oxide nanoparticles for CD163 detection in atherosclerosis by MRI (2015) (53)
Interferon-inducible protein-10 is highly expressed in rats with experimental nephrosis. (1996) (53)
Renal expression of parathyroid hormone-related protein (PTHrP) and PTH/PTHrP receptor in a rat model of tubulointerstitial damage. (1999) (53)
Atorvastatin modulates the profile of proteins released by human atherosclerotic plaques. (2007) (53)
Impact of soluble TWEAK and CD163/TWEAK ratio on long-term cardiovascular mortality in patients with peripheral arterial disease. (2011) (52)
Fn14 in podocytes and proteinuric kidney disease. (2013) (52)
Suppressor of Cytokine Signaling 1–Derived Peptide Inhibits Janus Kinase/Signal Transducers and Activators of Transcription Pathway and Improves Inflammation and Atherosclerosis in Diabetic Mice (2014) (52)
A possible common pathogenesis of the mesangial IgA glomerulonephritis in patients with Berger's disease and Schönlein-Henoch syndrome. (1980) (52)
Circulating human monocytes in the acute coronary syndrome express a characteristic proteomic profile. (2007) (52)
Interleukin-17A blockade reduces albuminuria and kidney injury in an accelerated model of diabetic nephropathy. (2019) (52)
Identifying the anti-inflammatory response to lipid lowering therapy: a position paper from the working group on atherosclerosis and vascular biology of the European Society of Cardiology. (2018) (52)
Long-term NSAID treatment directly decreases COX-2 and mPGES-1 production in the articular cartilage of patients with osteoarthritis. (2007) (52)
MIF, CD74 and other partners in kidney disease: tales of a promiscuous couple. (2013) (51)
Proteomic Analysis of Intraluminal Thrombus Highlights Complement Activation in Human Abdominal Aortic Aneurysms (2013) (51)
TWEAK transactivation of the epidermal growth factor receptor mediates renal inflammation (2013) (51)
Stimulation of Fc(alpha) receptors induces tyrosine phosphorylation of phospholipase C-gamma(1), phosphatidylinositol phosphate hydrolysis, and Ca2+ mobilization in rat and human mesangial cells. (1996) (51)
TWEAK and Fn14. New players in the pathogenesis of atherosclerosis. (2007) (51)
Pre-Existing Glomerular Immune Complexes Induce Polymorphonuclear Cell Recruitment Through an Fc Receptor-Dependent Respiratory Burst: Potential Role in the Perpetuation of Immune Nephritis 1 (2003) (51)
Acute renal failure associated to paroxysmal nocturnal haemoglobinuria leads to intratubular haemosiderin accumulation and CD163 expression. (2011) (50)
Hyperlipidemia-Associated Renal Damage Decreases Klotho Expression in Kidneys from ApoE Knockout Mice (2013) (50)
Renal tubulointerstitial damage caused by persistent proteinuria is attenuated in AT1-deficient mice: role of endothelin-1. (2001) (50)
Biology of atherosclerotic plaques: what we are learning from proteomic analysis. (2006) (50)
Phosphate, pyrophosphate, and vascular calcification: a question of balance (2015) (50)
Suppressors of cytokine signaling regulate angiotensin II-activated Janus kinase-signal transducers and activators of transcription pathway in renal cells. (2005) (50)
Lipophilic statins induce apoptosis of human vascular smooth muscle cells. (1999) (50)
Effect of a high dose of glucosamine on systemic and tissue inflammation in an experimental model of atherosclerosis aggravated by chronic arthritis. (2009) (49)
Suppressors of Cytokine Signaling Regulate Fc Receptor Signaling and Cell Activation during Immune Renal Injury1 (2004) (49)
Osteoprotegerin in Exosome-Like Vesicles from Human Cultured Tubular Cells and Urine (2013) (49)
Atorvastatin Reduces the Expression of Prostaglandin E2 Receptors in Human Carotid Atherosclerotic Plaques and Monocytic Cells: Potential Implications for Plaque Stabilization (2006) (49)
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update. (2018) (49)
Angiotensin III up-regulates genes involved in kidney damage in mesangial cells and renal interstitial fibroblasts. (1998) (48)
Reactive oxygen species-mediated signaling pathways in angiotensin II-induced MCP-1 expression of proximal tubular cells. (2005) (48)
Mesangial cells possess an asialoglycoprotein receptor with affinity for human immunoglobulin A. (1998) (48)
Gremlin Activates the Smad Pathway Linked to Epithelial Mesenchymal Transdifferentiation in Cultured Tubular Epithelial Cells (2014) (48)
A fibrin based model for rheumatoid synovitis (2003) (48)
Targeting metabolic disturbance in the diabetic heart (2015) (48)
Susceptibility to T Cell-Mediated Injury in Immune Complex Disease Is Linked to Local Activation of Renin-Angiotensin System: The Role of NF-AT Pathway1 (2002) (48)
Cardiovascular risk and antiangiogenic therapy for age-related macular degeneration. (2009) (47)
Natural history of IgA nephropathy in patients followed-up for more than ten years in Spain. (1987) (47)
Gremlin Is a Downstream Profibrotic Mediator of Transforming Growth Factor-Beta in Cultured Renal Cells (2013) (47)
CCL20 Is Increased in Hypercholesterolemic Subjects and Is Upregulated By LDL in Vascular Smooth Muscle Cells: Role of NF-&kgr;B (2011) (47)
T-cell dysfunctions in IgA nephropathy: specific abnormalities in the regulation of IgA synthesis. (1983) (47)
Angiotensin III activates nuclear transcription factor-kappaB in cultured mesangial cells mainly via AT(2) receptors: studies with AT(1) receptor-knockout mice. (2002) (47)
Increased rates of polymeric IgA synthesis by circulating lymphoid cells in IgA mesangial glomerulonephritis. (1982) (47)
Severe everolimus-associated pneumonitis in a renal transplant recipient. (2008) (47)
Renin-angiotensin system and renal damage: emerging data on angiotensin II as a proinflammatory mediator. (2001) (47)
Peptide inhibitor of NF-κB translocation ameliorates experimental atherosclerosis. (2013) (47)
Angiotensin II, the immune system and renal diseases: another road for RAS? (2003) (46)
Obstructive renal injury: from fluid mechanics to molecular cell biology (2010) (46)
Inhibition of Bromodomain and Extraterminal Domain Family Proteins Ameliorates Experimental Renal Damage. (2017) (46)
Regulation of matrix proteins and impact on vascular structure (2000) (46)
Sitagliptin ameliorates oxidative stress in experimental diabetic nephropathy by diminishing the miR-200a/Keap-1/Nrf2 antioxidant pathway (2017) (46)
Oxidative Stress, Macrophage Infiltration and CD163 Expression Are Determinants of Long-Term Renal Outcome in Macrohematuria-Induced Acute Kidney Injury of IgA Nephropathy (2012) (46)
EP2/EP4 signalling inhibits monocyte chemoattractant protein-1 production induced by interleukin 1β in synovial fibroblasts (2004) (46)
Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus (2015) (45)
Glomerular haematuria, renal interstitial haemorrhage and acute kidney injury. (2010) (45)
Soluble TWEAK plasma levels predict expansion of human abdominal aortic aneurysms. (2011) (45)
Interplay between hypercholesterolaemia and inflammation in atherosclerosis: Translating experimental targets into clinical practice (2018) (45)
Nrf2 Activation Provides Atheroprotection in Diabetic Mice Through Concerted Upregulation of Antioxidant, Anti-inflammatory, and Autophagy Mechanisms (2018) (45)
Genetic factors in primary IgA nephropathy. (1987) (45)
Biomarkers in cardiovascular medicine. (2009) (44)
Coexistence of Low Vitamin D and High Fibroblast Growth Factor-23 Plasma Levels Predicts an Adverse Outcome in Patients with Coronary Artery Disease (2014) (44)
Podocytes are new cellular targets of haemoglobin‐mediated renal damage (2018) (43)
Renoprotective effects of mineralocorticoid receptor blockers in patients with proteinuric kidney diseases. (2013) (43)
Proteomic strategies in the search of new biomarkers in atherothrombosis. (2010) (43)
Role of Bcl-xL in paracetamol-induced tubular epithelial cell death. (2005) (43)
Bisphenol A is an exogenous toxin that promotes mitochondrial injury and death in tubular cells (2018) (42)
ACE inhibitors and AT(1) receptor antagonists-beyond the haemodynamic effect. (2000) (42)
A European multicentre and open-label controlled randomized trial to evaluate the efficacy of Sequential treatment with TAcrolimus–Rituximab versus steroids plus cyclophosphamide in patients with primary MEmbranous Nephropathy: the STARMEN study (2015) (42)
The C-terminal module IV of connective tissue growth factor is a novel immune modulator of the Th17 response (2013) (42)
Immunoglobulin G Fc receptor deficiency prevents Alzheimer-like pathology and cognitive impairment in mice. (2012) (41)
ApoA-I/HDL-C levels are inversely associated with abdominal aortic aneurysm progression (2015) (41)
Adiponectin plasma levels are increased by atorvastatin treatment in subjects at high cardiovascular risk. (2008) (41)
Connective tissue growth factor induces renal fibrosis via epidermal growth factor receptor activation (2018) (41)
Angiotensin II Contributes to Renal Fibrosis Independently of Notch Pathway Activation (2012) (41)
TWEAK-Fn14 interaction enhances plasminogen activator inhibitor 1 and tissue factor expression in atherosclerotic plaques and in cultured vascular smooth muscle cells. (2011) (40)
Cluster TOF‐SIMS imaging: A new light for in situ metabolomics? (2008) (40)
Role of Endogenous Vascular Endothelial Growth Factor in Tubular Cell Protection Against Acute Cyclosporine Toxicity1 (2002) (40)
The role of IgA and IgG immune complexes in IgA nephropathy. (1984) (40)
2012 update on diabetic kidney disease: the expanding spectrum, novel pathogenic insights and recent clinical trials. (2012) (39)
Pathogenesis of glomerular haematuria. (2015) (39)
Glomerular Hematuria: Cause or Consequence of Renal Inflammation? (2019) (39)
Lipocalin-2 deficiency or blockade protects against aortic abdominal aneurysm development in mice. (2016) (39)
Integrin-linked kinase plays a key role in the regulation of angiotensin II-induced renal inflammation. (2014) (39)
Haematuria as a risk factor for chronic kidney disease progression in glomerular diseases: A review (2016) (39)
Suppressor of Cytokine Signaling-1 Peptidomimetic Limits Progression of Diabetic Nephropathy. (2017) (39)
Increased levels of thioredoxin in patients with abdominal aortic aneurysms (AAAs). A potential link of oxidative stress with AAA evolution. (2010) (39)
Decreased circulating Fas ligand in patients with familial combined hyperlipidemia or carotid atherosclerosis: normalization by atorvastatin. (2004) (38)
Evidence for the involvement of IgE-basophil system in acute serum sickness. (1976) (38)
Presence in normal human urine of a hypotensive and platelet-activating phospholipid. (1983) (38)
Plasma profiling by a protein array approach identifies IGFBP-1 as a novel biomarker of abdominal aortic aneurysm. (2012) (38)
A Nanoconjugate Apaf-1 Inhibitor Protects Mesothelial Cells from Cytokine-Induced Injury (2009) (38)
Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy. (2015) (38)
Calcineurin inhibitors recruit protein kinases JAK2 and JNK, TLR signaling and the UPR to activate NF-κB-mediated inflammatory responses in kidney tubular cells. (2013) (37)
Fcγ receptor deficiency attenuates diabetic nephropathy. (2012) (37)
Peptide-based inhibition of IκB kinase/nuclear factor-κB pathway protects against diabetes-associated nephropathy and atherosclerosis in a mouse model of type 1 diabetes (2015) (37)
Inhibition by L-arginine of the endothelin-mediated increase in cytosolic calcium in human neutrophils. (1991) (37)
Interactions between aldosterone and connective tissue growth factor in vascular and renal damage in spontaneously hypertensive rats (2007) (37)
Administration of IgG Fc Fragments Prevents Glomerular Injury in Experimental Immune Complex Nephritis1 (2000) (37)
TWEAK/Fn14 interaction promotes oxidative stress through NADPH oxidase activation in macrophages. (2015) (36)
SOCS1-targeted therapy ameliorates renal and vascular oxidative stress in diabetes via STAT1 and PI3K inhibition (2018) (36)
Inhibition of Caspases Improves Bacterial Clearance in Experimental Peritonitis (2003) (36)
Proteome changes in the myocardium of experimental chronic diabetes and hypertension: role of PPARα in the associated hypertrophy. (2012) (36)
New kids in the block: the role of FasL and Fas in kidney damage. (1999) (36)
Cardiovascular risk biomarkers in CKD: the inflammation link and the road less traveled (2012) (36)
Long-term blood pressure control prevents oxidative renal injury. (2005) (35)
Endothelin-1 upregulation in the kidney of uninephrectomized spontaneously hypertensive rats and its modification by the angiotensin-converting enzyme inhibitor quinapril. (1997) (35)
Fibrin generated in the synovial fluid activates intimal cells from their apical surface: a sequential morphological study in antigen-induced arthritis. (2003) (35)
Heat-shock proteins in cardiovascular disease. (2011) (35)
Apoptotic cell death in renal injury: the rationale for intervention. (2002) (35)
Up-regulation of parathyroid hormone-related protein in folic acid-induced acute renal failure. (2001) (35)
HMGB1 Expression and Secretion Are Increased Via TWEAK–Fn14 Interaction in Atherosclerotic Plaques and Cultured Monocytes (2013) (34)
Genetic deletion or TWEAK blocking antibody administration reduce atherosclerosis and enhance plaque stability in mice (2014) (34)
Role and regulation of apoptotic cell death in the kidney. Y2K update. (2000) (34)
Modulation of cell recruitment by anti-inflammatory agents in antigen-induced arthritis (2002) (34)
Long-term protective effect of UR-12670 after warm renal ischemia in uninephrectomized rats. (1999) (34)
TNF‐related weak inducer of apoptosis (TWEAK) regulates junctional proteins in tubular epithelial cells via canonical NF‐κB pathway and ERK activation (2015) (34)
Bcl-xL overexpression protects from apoptosis induced by HMG-CoA reductase inhibitors in murine tubular cells. (2003) (34)
Losartan improves resistance artery lesions and prevents CTGF and TGF-beta production in mild hypertensive patients. (2006) (34)
Regulation of apoptosis by lethal cytokines in human mesothelial cells. (2003) (33)
CD163-Macrophages Are Involved in Rhabdomyolysis-Induced Kidney Injury and May Be Detected by MRI with Targeted Gold-Coated Iron Oxide Nanoparticles (2016) (33)
GSK3, snail, and adhesion molecule regulation by cyclosporine A in renal tubular cells. (2012) (33)
Nitric oxide production in renal cells by immune complexes: Role of kinases and nuclear factor-κB (2002) (33)
Sitagliptin improved glucose assimilation in detriment of fatty-acid utilization in experimental type-II diabetes: role of GLP-1 isoforms in Glut4 receptor trafficking (2018) (33)
Effects of oral paricalcitol on secondary hyperparathyroidism and proteinuria of kidney transplant patients. (2013) (33)
Isolation of circulating human monocytes with high purity for proteomic analysis (2004) (33)
Protective Role of Nrf2 in Renal Disease (2020) (33)
Atrasentan for the treatment of diabetic nephropathy (2017) (33)
A Polymeric Nanomedicine Diminishes Inflammatory Events in Renal Tubular Cells (2013) (33)
Gene delivery of suppressors of cytokine signaling (SOCS) inhibits inflammation and atherosclerosis development in mice (2015) (33)
Thioredoxin-1/peroxiredoxin-1 as sensors of oxidative stress mediated by NADPH oxidase activity in atherosclerosis. (2015) (33)
Tubular Overexpression of Gremlin Induces Renal Damage Susceptibility in Mice (2014) (32)
Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry (2019) (32)
Comparison of the protein profile of established and regressed hypertension-induced left ventricular hypertrophy. (2006) (32)
Detection of immediate hypersensitivity in rabbits by direct basophil degranulation. (1977) (32)
Binding kinetics of monomeric and aggregated IgG to Kupffer cells and hepatocytes of mice. (1984) (31)
Defining protein-energy wasting syndrome in chronic kidney disease: prevalence and clinical implications. (2014) (31)
Ethanol beverages containing polyphenols decrease nuclear factor kappa-B activation in mononuclear cells and circulating MCP-1 concentrations in healthy volunteers during a fat-enriched diet. (2007) (31)
HMG-CoA Reductase Inhibitors Reduce IκB Kinase Activity Induced by Oxidative Stress in Monocytes and Vascular Smooth Muscle Cells (2005) (30)
Rat serum sickness: possible role of inflammatory mediators allowing deposition of immune complexes in the glomerular basement membrane. (1982) (30)
Atorvastatin modifies the protein profile of circulating human monocytes after an acute coronary syndrome (2009) (30)
Expression of Smac/Diablo in tubular epithelial cells and during acute renal failure. (2003) (30)
Simvastatin inhibits the migration and adhesion of monocytic cells and disorganizes the cytoskeleton of activated endothelial cells. (2006) (30)
From tissue iron retention to low systemic haemoglobin levels, new pathophysiological biomarkers of human abdominal aortic aneurysm (2014) (30)
Albumin-induced apoptosis of tubular cells is modulated by BASP1 (2015) (30)
Soluble TWEAK is associated with atherosclerotic burden in patients with chronic kidney disease. (2013) (30)
Nrf2 Plays a Protective Role Against Intravascular Hemolysis-Mediated Acute Kidney Injury (2019) (30)
Phenytoin in IgA nephropathy: a long-term controlled trial. (1984) (30)
Vitamin D, vitamin D receptor and the importance of its activation in patients with chronic kidney disease. (2015) (30)
Targeted and non-targeted metabolic time trajectory in plasma of patients after acute coronary syndrome. (2011) (29)
Chemokines, chemokine receptors and renal disease. (1999) (29)
The C-terminal module IV of connective tissue growth factor, through EGFR/Nox1 signaling, activates the NF-κB pathway and proinflammatory factors in vascular smooth muscle cells. (2015) (29)
Proteomic and Metabolomic Profiles in Atherothrombotic Vascular Disease (2010) (29)
Common pathways of hypercholesterolemia and hypertension leading to atherothrombosis: the need for a global approach in the management of cardiovascular risk factors (2007) (28)
Hepatic and kidney uptake of soluble monomeric and polymeric IgA aggregates. (1984) (28)
Bladder cancer after cyclophosphamide therapy for lupus nephritis. (1992) (28)
Apoptosis in renal diseases. (1996) (28)
Ursolic acid inhibits neointima formation in the rat carotid artery injury model. (2006) (28)
Gremlin Regulates Tubular Epithelial to Mesenchymal Transition via VEGFR2: Potential Role in Renal Fibrosis (2018) (28)
Quantitative HDL Proteomics Identifies Peroxiredoxin-6 as a Biomarker of Human Abdominal Aortic Aneurysm (2016) (28)
Role of platelet-activating factor in adriamycin-induced nephropathy in rats. (1987) (27)
The central role of nuclear factor-kappa B in mesangial cell activation. (1999) (27)
Effect of intensive atorvastatin therapy on prostaglandin E2 levels and metalloproteinase-9 activity in the plasma of patients with non-ST-elevation acute coronary syndrome. (2008) (27)
Apoptosis of Vascular Smooth Muscle Cells in Culture 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase and Isoprenylation Inhibitors Induce (1998) (27)
Role of connective tissue growth factor in vascular and renal damage associated with hypertension in rats. Interactions with angiotensin II (2006) (27)
Role of pyrophosphate in vascular calcification in chronic kidney disease. (2017) (27)
Toll-Like Receptors in Acute Kidney Injury (2021) (27)
Metabolites secreted by human atherothrombotic aneurysms revealed through a metabolomic approach. (2011) (26)
Modulation of renal tubular cell survival: where is the evidence? (2006) (26)
Use of Proton-Pump Inhibitors Predicts Heart Failure and Death in Patients with Coronary Artery Disease (2017) (26)
Phenotypic Characterization of Macrophages from Rat Kidney by Flow Cytometry. (2016) (26)
Characterization of the human atheroma plaque secretome by proteomic analysis. (2007) (26)
The role of interleukin 2 (IL-2) and serum-soluble IL-2 receptor cells in idiopathic IgA nephropathy. (1992) (26)
Haematuria Increases Progression of Advanced Proteinuric Kidney Disease (2015) (26)
Study of the capillary electrophoresis profile of intact α-1-acid glycoprotein isoforms as a biomarker of atherothrombosis. (2011) (26)
Immunological studies in a familial IgA nephropathy. (1983) (25)
The intercrine superfamily and renal disease. (1993) (25)
IL‐1‐like production in adriamycin‐induced nephrotic syndrome in the rat (1992) (25)
Targeting chemokines in proteinuria-induced renal disease (2012) (25)
Quinapril decreases renal endothelin-1 expression and synthesis in a normotensive model of immune-complex nephritis. (1997) (25)
Targeting inflammation in cardiovascular diseases. still a neglected field? (2012) (25)
[Connective tissue growth factor (CTGF): a key factor in the onset and progression of kidney damage]. (2009) (25)
Gene Deficiency in Activating Fcγ Receptors Influences the Macrophage Phenotypic Balance and Reduces Atherosclerosis in Mice (2013) (25)
Cartilage and bone biological markers in the synovial fluid of osteoarthritic patients after hyaluronan injections in the knee. (2001) (25)
Platelet-activating factor stimulates gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: role of TGF-beta. (1997) (25)
Interstitial mononuclear cell infiltrates in experimental nephrosis: effect of PAF antagonist. (1989) (24)
Deferasirox-induced iron depletion promotes BclxL downregulation and death of proximal tubular cells (2017) (24)
IgA serology in recurrent and non-recurrent IgA nephropathy after renal transplantation. (1995) (24)
Angiotensin II, via angiotensin receptor type 1/nuclear factor-κB activation, causes a synergistic effect on interleukin-1-β-induced inflammatory responses in cultured mesangial cells (2015) (24)
Interaction of mesangial cells with IgA and IgG immune complexes: a possible mechanism of glomerular injury in IgA nephropathy. (1993) (24)
Immunoinflammation in Diabetic Nephropathy: Molecular Mechanisms and Therapeutic Options (2012) (24)
Hemoglobin induces monocyte recruitment and CD163-macrophage polarization in abdominal aortic aneurysm. (2015) (24)
Hyperphosphatemia and hyperparathyroidism in incident chronic kidney disease patients. (2008) (24)
Chronic arthritis aggravates vascular lesions in rabbits with atherosclerosis: a novel model of atherosclerosis associated with chronic inflammation. (2008) (24)
Circulating fibroblast growth factor‐23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease (2016) (24)
3,4-DGE is cytotoxic and decreases HSP27/HSPB1 in podocytes (2013) (23)
Gremlin and renal diseases: ready to jump the fence to clinical utility? (2018) (23)
Involvement of platelet‐activating factor and tumour necrosis factor in the pathogenesis of joint inflammation in rabbits (1992) (23)
A slit in podocyte death. (2008) (23)
Soluble Fas ligand plasma levels are associated with forearm reactive hyperemia in subjects with coronary artery disease: a novel biomarker of endothelial function? (2008) (23)
Proteomic analysis of early left ventricular hypertrophy secondary to hypertension: modulation by antihypertensive therapies. (2006) (23)
Interplay between HSP90 and Nrf2 pathways in diabetes-associated atherosclerosis. (2017) (23)
Immunological abnormalities in healthy relatives of patients with IgA nephropathy. (1985) (23)
Expression of insulin receptor (IR) A and B isoforms, IGF-IR, and IR/IGF-IR hybrid receptors in vascular smooth muscle cells and their role in cell migration in atherosclerosis (2016) (23)
Early prevention of diabetes microvascular complications in people with hyperglycaemia in Europe. ePREDICE randomized trial. Study protocol, recruitment and selected baseline data (2020) (23)
Statins to prevent cardiovascular events in hypertensive patients. The ASCOT-LLA study. (2004) (23)
Association of ficolin‐3 with abdominal aortic aneurysm presence and progression (2017) (23)
The importance of the Fc receptors for IgA in the recognition of IgA by mouse liver cells: its comparison with carbohydrate and secretory component receptors. (1986) (23)
Could IL-17A Be a Novel Therapeutic Target in Diabetic Nephropathy? (2020) (23)
3,4-Dideoxyglucosone-3-ene as a mediator of peritoneal demesothelization. (2008) (22)
Targeting Nrf2 in Protection Against Renal Disease. (2017) (22)
Metabolomic study of plasma of patients with abdominal aortic aneurysm (2012) (22)
Treatment with amlodipine and atorvastatin has additive effect on blood and plaque inflammation in hypertensive patients with carotid atherosclerosis. (2008) (22)
Handling of soluble IgA aggregates by the mononuclear phagocytic system in mice. A comparison with IgG aggregates. (1982) (22)
TWEAK Promotes Peritoneal Inflammation (2014) (22)
Is there a role for specific anti-TNF strategies in glomerular diseases? (1995) (22)
Soluble TWEAK and atheromatosis progression in patients with chronic kidney disease. (2017) (22)
Overexpression of extracellular matrix proteins in renal tubulointerstitial cells by platelet-activating-factor stimulation. (1998) (22)
Anti-inflammatory effect of a PAF receptor antagonist and a new molecule with antiproteinase activity in an experimental model of acute urate crystal arthritis. (1996) (22)
Macroscopic hematuria and proteinuria preceding renal IgA deposition in patients with IgA nephropathy. (1991) (21)
Paricalcitol Inhibits Aldosterone-Induced Proinflammatory Factors by Modulating Epidermal Growth Factor Receptor Pathway in Cultured Tubular Epithelial Cells (2015) (21)
Interleukin-17A induces vascular remodeling of small arteries and blood pressure elevation. (2020) (21)
Modulation of renal kallikrein by a high potassium diet in rats with intense proteinuria. (2006) (21)
Characteristics of IgA and macromolecular IgA in sera from IgA nephropathy transplanted patients with and without IgAN recurrence. (1995) (21)
Eplerenone enhances cardioprotective effects of standard heart failure therapy through matricellular proteins in hypertensive heart failure (2013) (21)
Evidence of an immediate hypersensitivity mechanism in systemic lupus erythematosus. (1980) (21)
Gremlin activates the Notch pathway linked to renal inflammation. (2018) (21)
SOCS1-Derived Peptide Administered by Eye Drops Prevents Retinal Neuroinflammation and Vascular Leakage in Experimental Diabetes (2019) (21)
CCL20 blockade increases the severity of nephrotoxic folic acid‐induced acute kidney injury (2018) (21)
Tyrphostins as potential therapeutic agents for acute kidney injury. (2010) (20)
Vascular proteomics and the discovery process of clinical biomarkers: The case of TWEAK (2011) (20)
A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis (2019) (20)
Immunopathogenetic aspects of IgA nephropathy. (1983) (20)
Role of Macrophages and Related Cytokines in Kidney Disease (2021) (20)
Atorvastatin decreases elevated soluble CD40L in subjects at high cardiovascular risk. Atorvastatin on inflammatory markers study: a substudy of ACTFAST. (2008) (20)
Endothelin-1 induces loss of proteoglycans and enhances fibronectin and collagen production in cultured rabbit synovial cells. (1996) (20)
Evidence of high polymeric IgA levels in serum of patients with Berger's disease and its modification with phenytoin treatment. (1979) (20)
Role of chemokines in proteinuric kidney disorders (2014) (20)
Tumor Necrosis Factor‐Like Weak Inducer of Apoptosis or Fn14 Deficiency Reduce Elastase Perfusion‐Induced Aortic Abdominal Aneurysm in Mice (2014) (20)
Cardiovascular Damage in COVID-19: Therapeutic Approaches Targeting the Renin-Angiotensin-Aldosterone System (2020) (20)
Nephrotic syndrome complicating chronic visceral leishmaniasis: re-emergence in patients with AIDS. (2008) (20)
High prevalence of winter 25-hydroxyvitamin D deficiency despite supplementation according to guidelines for hemodialysis patients (2012) (19)
VEGFR2 Blockade Improves Renal Damage in an Experimental Model of Type 2 Diabetic Nephropathy (2020) (19)
Presence of shared idiotypes in serum and immune complexes in patients with IgA nephropathy. (1987) (19)
SAMe restores the changes in the proliferation and in the synthesis of fibronectin and proteoglycans induced by tumour necrosis factor alpha on cultured rabbit synovial cells. (1997) (19)
Inflammatory Cytokines and Survival Factors from Serum Modulate Tweak-Induced Apoptosis in PC-3 Prostate Cancer Cells (2012) (19)
Use of sevelamer in chronic kidney disease: beyond phosphorus control. (2015) (19)
The proteome of endothelial cells. (2007) (19)
The 80‐kD fibronectin fragment increases the production of fibronectin and tumour necrosis factor‐alpha (TNF‐α) in cultured mesangial cells (1997) (19)
Nitric oxide production in renal cells by immune complexes: Role of kinases and nuclear factor-kappaB. (2002) (19)
Combination of biomarkers of vascular calcification and sTWEAK to predict cardiovascular events in chronic kidney disease. (2018) (18)
Tight blood pressure control decreases apoptosis during renal damage. (2004) (18)
Proteomic Approach to the Study of Statin Pleiotropy in Kidney Transplant Patients (2011) (18)
Soluble TWEAK levels predict the presence of carotid atherosclerotic plaques in subjects free from clinical cardiovascular diseases. (2015) (18)
Increased galectin-3 levels are associated with abdominal aortic aneurysm progression and inhibition of galectin-3 decreases elastase-induced AAA development. (2017) (18)
Glomerular up-regulation of EIIIA and V120 fibronectin isoforms in proliferative immune complex nephritis. (1996) (18)
TGF-Beta Blockade Increases Renal Inflammation Caused by the C-Terminal Module of the CCN2 (2015) (18)
PDGF and the progression of renal disease (2014) (17)
Characterization of circulating idiotypes containing immune complexes and their presence in the glomerular mesangium in patients with IgA nephropathy. (1989) (17)
Unravelling fibrosis: two newcomers and an old foe. (2010) (17)
Proteomic approach in the search of new cardiovascular biomarkers. (2005) (17)
Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD. (2016) (16)
The Prognostic Value of High-Sensitive Troponin I in Stable Coronary Artery Disease Depends on Age and Other Clinical Variables (2015) (16)
Fibronectin (FN) decreases glomerular lesions and synthesis of tumour necrosis factor‐alpha (TNF‐α), platelet‐activating factor (PAF) and FN in proliferative glomerulonephritis (1995) (16)
Paraoxonase-1 overexpression prevents experimental abdominal aortic aneurysm progression. (2016) (16)
The emerging role of parathyroid hormone-related protein as a renal regulating factor. (2000) (16)
Endogenous NAMPT dampens chemokine expression and apoptotic responses in stressed tubular cells. (2014) (16)
Proteomics in atherothrombosis: a future perspective (2007) (15)
Trail and vascular injury. (2007) (15)
Acute kidney injury transcriptomics unveils a relationship between inflammation and ageing. (2012) (15)
Cyclosporin A prevents the histologic damage of antigen arthritis without inducing fibrosis. (2000) (15)
The identification of IgA receptors in human mesangial cells: in the search for "Eldorado". (2002) (15)
Macrophages and Recently Identified Forms of Cell Death (2014) (15)
Individualization of Dialysate Calcium Concentration According to Baseline Pre-Dialysis Serum Calcium (2014) (15)
The role of platelet-activating factor (PAF) in experimental glomerular injury (1991) (15)
Immunological studies in familial and sporadic IgA nephropathy. (1987) (14)
Long-term organ protection by doxazosin and/or quinapril as antihypertensive therapy. (2006) (14)
Prostaglandin E2 receptors EP1 and EP4 are up-regulated in rabbit chondrocytes by IL-1beta, but not by TNFalpha. (2007) (14)
A decrease in intact parathyroid hormone (iPTH) levels is associated with higher mortality in prevalent hemodialysis patients (2017) (14)
Low‐Density Lipoprotein Cholesterol and High‐Sensitivity C‐Reactive Protein Lowering With Atorvastatin in Patients of South Asian Compared With European Origin: Insights From the Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration (ACTFAST) Study (2012) (14)
TWEAKing renal injury. (2008) (14)
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase the binding activity and nuclear level of Oct-1 in mononuclear cells. (2002) (14)
Statin use in aortic aneurismal disease to prevent progression and cardiovascular events: review of experimental and clinical data C. (2013) (14)
Differential profile in inflammatory and mineral metabolism biomarkers in patients with ischemic heart disease without classical coronary risk factors. (2015) (14)
Alkalosis and Dialytic Clearance of Phosphate Increases Phosphatase Activity: A Hidden Consequence of Hemodialysis (2016) (13)
[Transcriptomics illustrate a deadly TRAIL to diabetic nephropathy]. (2009) (13)
Important abnormalities of bone mineral metabolism are present in patients with coronary artery disease with a mild decrease of the estimated glomerular filtration rate (2016) (13)
Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease (2016) (13)
A platelet activating factor receptor antagonist prevents the development of chronic arthritis in mice. (1999) (13)
Vascular protection of dual therapy (atorvastatin-amlodipine) in hypertensive patients. (2006) (13)
Characterization of circulating human monocytes by proteomic analysis. (2007) (13)
Beneficial effect of fibronectin administration on chronic nephritis in rats. (1990) (13)
Mechanisms of action of statins in stroke (2007) (13)
Influence of dialysis membrane composition on plasma bisphenol A levels during online hemodiafiltration (2018) (13)
Involvement of platelet-activating factor in renal processes. (1989) (13)
Effect of atorvastatin on circulating hsCRP concentrations: a sub-study of the achieve cholesterol targets fast with atorvastatin stratified titration (ACTFAST) study. (2010) (13)
TWEAK blockade decreases atherosclerotic lesion size and progression through suppression of STAT1 signaling in diabetic mice (2017) (12)
Inhibition of neutrophil migration by serum IgA from patients with IgA nephropathy. (1982) (12)
Molecular mediators of favism-induced acute kidney injury. (2014) (12)
Urinary excretion of platelet-activating factor in human and experimental nephrosis. (1996) (12)
Characterization of HSP27 phosphorylation sites in human atherosclerotic plaque secretome. (2007) (12)
Cortisol levels are associated with mortality risk in hemodialysis patients. (2014) (12)
Potential role of insulin receptor isoforms and IGF receptors in plaque instability of human and experimental atherosclerosis (2018) (12)
Proteomics in atherosclerosis (2008) (12)
IgA nephropathy: association of a history of macroscopic hematuria episodes with increased production of polymeric IgA. (1987) (12)
Label‐free proteomic analysis of red blood cell membrane fractions from abdominal aortic aneurysm patients (2014) (12)
Effect of bombesin receptor subtype-3 and its synthetic agonist on signaling, glucose transport and metabolism in myocytes from patients with obesity and type 2 diabetes (2015) (12)
IL‐1β and IL‐6 stimulate the production of platelet‐activating factor (PAF) cultured rabbit synovial cells (1995) (12)
Cooperation between tumor necrosis factor (TNF) and platelet-activating factor (PAF) in the inflammatory response. (1990) (12)
Modulation of Angiotensin II Effects, A Potential Novel Approach to Inflammatory and Immune Diseases (2003) (12)
Gremlin, A Potential Urinary Biomarker of Anca-Associated Crescentic Glomerulonephritis (2019) (12)
Clinical significance of polymeric and monomeric IgA complexes in patients with IgA nephropathy. (1986) (12)
Galectin-3 is Associated with Cardiovascular Events in Post-Acute Coronary Syndrome Patients with Type-2 Diabetes (2020) (11)
Endothelial Dysfunction, Inflammation, and Statins: New Evidence (2004) (11)
IN-VITRO BASOPHIL DEGRANULATION IN DRUG-SUSPECTED ACUTE RENAL FAILURE (1977) (11)
Potential factors governing extracellular matrix production by mesangial cells: their relevance for the pathogenesis of IgA nephropathy. (1995) (11)
Molecular evidence of field cancerization initiated by diabetes in colon cancer patients (2019) (11)
HSP 27 / HSPB 1 as an adaptive podocyte antiapoptotic protein activated by high glucose and angiotensin II (2011) (11)
Proteomics and metabolomics in biomarker discovery for cardiovascular diseases: progress and potential (2016) (11)
Transcriptome of hypertension-induced left ventricular hypertrophy and its regression by antihypertensive therapies (2009) (11)
Parathormone levels are independently associated with the presence of left ventricular hypertrophy in patients with coronary artery disease (2014) (11)
New players in the pathogenesis of atherosclerosis (2007) (11)
Ciprofloxacin-associated tubulointerstitial nephritis with linear tubular basement membrane deposits. (1992) (10)
Usefulness of serum interleukin 2 receptor levels in renal allograft recipients. (1992) (10)
Translational study of the Notch pathway in hypertensive nephropathy. (2014) (10)
Presence of specific IgA immune complexes in IgA nephropathy. (1984) (10)
Hydrolysis of Extracellular Pyrophosphate increases in post-hemodialysis plasma (2018) (10)
Targeting NF-κB by the Cell-Permeable NEMO-Binding Domain Peptide Improves Albuminuria and Renal Lesions in an Experimental Model of Type 2 Diabetic Nephropathy (2020) (9)
Lethal activity of FADD death domain in renal tubular epithelial cells. (2006) (9)
Cell Stress Proteins in Atherothrombosis (2012) (9)
Paricalcitol for reduction of albuminuria in diabetes (2011) (9)
Vascular proteomics, a translational approach: from traditional to novel proteomic techniques (2009) (9)
Clinical and Population Studies Peripheral Artery Disease Is Associated With a High CD 163 / TWEAK Plasma Ratio (2010) (9)
Bcl-xL Prevents Peritoneal Dialysis Solution-Induced Leukocyte Apoptosis (2008) (9)
N-Terminal Pro-Brain Natriuretic Peptide Is Associated with a Future Diagnosis of Cancer in Patients with Coronary Artery Disease (2015) (8)
[TWEAK, the facilitator of acute kidney injury]. (2008) (8)
Prostaglandin E2 receptors EP1 and EP4 are up-regulated in rabbit chondrocytes by IL-1β, but not by TNFα (2007) (8)
Defective hepatic handling of IgA immune aggregates by mice with experimental IgA nephropathy. (1989) (8)
[Role of polymeric IgA in the pathogenesis of IgA nephropathy]. (1983) (8)
CD163 deficiency increases foam cell formation and plaque progression in atherosclerotic mice (2020) (8)
Gliotoxin Inhibits Neointimal Hyperplasia after Vascular Injury in Rats (2008) (8)
Protective effect of suppressor of cytokine signalling 1‐based therapy in experimental abdominal aortic aneurysm (2020) (8)
LDL induces parathyroid hormone-related protein expression in vascular smooth muscle cells: Modulation by simvastatin. (2008) (8)
TRAF3 Modulation: Novel Mechanism for the Anti-inflammatory Effects of the Vitamin D Receptor Agonist Paricalcitol in Renal Disease. (2020) (8)
Fcγ receptor activation mediates vascular inflammation and abdominal aortic aneurysm development (2021) (8)
Anti-inflammatory, antioxidant and renoprotective effects of SOCS1 mimetic peptide in the BTBR ob/ob mouse model of type 2 diabetes (2020) (8)
A simple method for determining polymeric IgA-containing immune complexes. (1983) (8)
Phase IV prospective clinical study to evaluate the effect of taurine on liver function in postsurgical adult patients requiring parenteral nutrition. (2014) (7)
Juxtaglomerular apparatus hyperplasia under dual angiotensin blockade. A footprint of adequate RAS inhibition or a concern for renal fibrosis? (2012) (7)
CCN2 (Cellular Communication Network Factor 2) Deletion Alters Vascular Integrity and Function Predisposing to Aneurysm Formation (2021) (7)
Changes in the pattern of fibronectin mRNA alternative splicing in acute experimental mesangioproliferative nephritis. (1999) (7)
Antifibroproliferative effect of tenidap in chronic antigen-induced arthritis. (1997) (7)
Diabetes‐mediated promotion of colon mucosa carcinogenesis is associated with mitochondrial dysfunction (2019) (7)
Detection and characterization of circulating and glomerular immune complexes in experimental IgA nephropathy. (1990) (7)
Recurrent acute postinfectious glomerulonephritis. (2006) (7)
Angiotensin II (AngII) activates nuclear factor-κB via AT1 and AT2 receptors in the kidney (1999) (7)
Anti-inflammatory Actions of Quinapril (2007) (7)
MCP-1 Predicts Recurrent Cardiovascular Events in Patients with Persistent Inflammation (2021) (7)
Immunologic Aspects of IgA Nephropathy in Humans (1984) (6)
TWEAK and the kidney: the dual role of a multifunctional cytokine. (2011) (6)
The proteomic approach in the development of prognostic biomarkers in atherothrombosis. (2009) (6)
IL-1 beta and IL-6 stimulate the production of platelet-activating factor (PAF) by cultured rabbit synovial cells. (1995) (6)
Correction of hypocalcemia allows optimal recruitment of FGF-23-dependent phosphaturic mechanisms in acute hyperphosphatemia post-phosphate enema (2013) (6)
Impact of post-dialysis calcium level on ex vivo rat aortic wall calcification (2017) (6)
Risk in Dosing Regimens for 25-OH Vitamin D Supplementation in Chronic Haemodialysis Patients (2012) (6)
The importance of bisphenol A, an uraemic toxin from exogenous sources, in haemodialysis patients. (2017) (6)
Aterosclerosis e inflamación: papel central del factor de transcripción NF-κB (2002) (6)
Bisphenol S is a haemodialysis-associated xenobiotic that is less toxic than bisphenol A (2020) (6)
Studies of Piroxicam Absorption by Oral Mucosa (2002) (6)
PAF, a potent proinflammatory mediator, looking for its role in the pathogenesis of joint damage (1997) (6)
IL-17A as a Potential Therapeutic Target for Patients on Peritoneal Dialysis (2020) (6)
Involvement of lipid mediators in the pathogenesis of experimental nephrosis in rats: its pharmacological modulation. (1991) (6)
Abnormalities of immune regulation in patients with IgA mesangial glomerulonephritis (Berger's disease). (1983) (6)
Analysis of antihypertensive drugs in the heart of animal models: a proteomic approach. (2007) (6)
Design and rationale of a multicentre, randomised, double-blind, placebo-controlled clinical trial to evaluate the effect of vitamin D on ventricular remodelling in patients with anterior myocardial infarction: the VITamin D in Acute Myocardial Infarction (VITDAMI) trial (2016) (6)
Vitamina D, síndrome metabólico y diabetes mellitus (2014) (5)
DNA release and appearance of antinuclear antibodies in chronic hemodialysis patients. (1982) (5)
Proteomic Analysis of Circulating Monocytes Identifies Cathepsin D as A Potential Novel Plasma Marker of Acute Coronary Syndromes (2008) (5)
Long-term treatment with an ACE inhibitor or an AT1 antagonist avoids hypertension-induced inflammation in the kidney. (2006) (5)
Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities. (2021) (5)
The pleiotropic effects of paricalcitol: Beyond bone-mineral metabolism. (2016) (5)
Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities. (2021) (5)
Parathormone levels add prognostic ability to N‐terminal pro‐brain natriuretic peptide in stable coronary patients (2021) (5)
Kidney microRNA Expression Pattern in Type 2 Diabetic Nephropathy in BTBR Ob/Ob Mice (2022) (5)
Taming Apoptosis in Peritoneal Dialysis (2009) (5)
[Proteomics and cardiovascular disease]. (2003) (5)
ACE inhibitors and AT 1 receptor antagonists—beyond the haemodynamic e ﬀ ect (2000) (5)
Monocyte Chemoattractant Protein-1 Is an Independent Predictor of Coronary Artery Ectasia in Patients with Acute Coronary Syndrome (2020) (5)
Absence of an anaphylactic vasopermeability mechanism for immune complex deposition in the Heymann nephritis of rats. (1980) (5)
Evidence suggesting a role for platelet-activating factor (PAF) in experimental nephrotic syndrome. (1990) (5)
Adverse effects of the renal accumulation of haem proteins. Novel therapeutic approaches. (2018) (5)
Defective function of the mononuclear phagocytic system in rats with chronic nephritis. Evidence of a decreased degradation of IgG aggregates by Kupffer cells. (1988) (5)
ANGIOTENSIN III INCREASES MONOCYTIC CHEMOTACTIC PROTEIN-1 AND ACTIVATES NUCLEAR TRANSCRIPTION FACTORS ±kB AND ACTIVATOR PROTEIN-1 IN CULTURED MESANGIAL AND MONONUCLEAR CELLS: 2C.6 (2000) (5)
Statins: Could an old friend help the fight against COVID-19? (2020) (4)
Comentario a: Sesión de hemodiálisis: la tormenta perfecta para la calcificación vascular (2016) (4)
Phenytoin in the treatment of IgA mesengial glomerulonephritis (Berger's disease) (1981) (4)
Handling of IgA immune aggregates by liver cells. (1984) (4)
EVIDENCE OF SENSITIZED BASOPHILS IN RENAL TRANSPLANTED PATIENTS (1980) (4)
[Impact of plasma pro-B-type natriuretic peptide amino-terminal and galectin-3 levels on the predictive capacity of the LIPID Clinical Risk Scale in stable coronary disease]. (2015) (4)
IMMUNOREGULATION ABNORMALITIES IN PATIENTS WITH IgA NEPHROPATHY * (1983) (4)
Correction: Sitagliptin Reduces Cardiac Apoptosis, Hypertrophy and Fibrosis Primarily by Insulin-Dependent Mechanisms in Experimental type-II Diabetes. Potential Roles of GLP-1 Isoforms (2013) (4)
ACE gene polymorphism and the prognosis and treatment of overt diabetic nephropathy (2008) (4)
The role of circulating immune complexes and the liver in the development of IgA nephropathy in mice. (1987) (4)
Elevated plasma fibronectin levels in rats with immune and toxic glomerular diseases. (1990) (4)
Colon cancer modulation by a diabetic environment: A single institutional experience (2017) (4)
Podocyte and tubular involvement in AngioJet-induced kidney injury (2019) (4)
[Endothelial dysfunction, inflammation and statins: new evidences]. (2004) (4)
Intensive treatment with statins and the progression of cardiovascular diseases: the beginning of a new era? (2004) (4)
Comment to: Haemodialysis session: The perfect storm for vascular calcification. (2016) (4)
The effect of the injection of a synthetic platelet-activating factor (PAF-acether) on the fate of IgG aggregates in mice. (1982) (4)
Increased rates ofpolymeric IgAsynthesis bycirculating lymphoid cells inIgAmesangial glomerulonephritis (1982) (3)
Sun exposure influences the prognostic power of components of mineral metabolism in patients with coronary artery disease. (2017) (3)
Expression and synthesis of cross-reactive idiotypic antibodies by peripheral blood lymphocytes and their suppression by anti-idiotypes in patients with IgA nephropathy. (1991) (3)
Statins improve visual field alterations related to hypercholesterolemia. (2010) (3)
Presence of circulating antibodies against brush border antigens (Fx1A) in a patient with membranous nephropathy and bilateral pyeloureteral stenosis. Comparison with idiopathic membranous nephropathy. (1992) (3)
Delayed graft function and cotrimoxazole. (2011) (3)
Protective effect of suppressor of cytokine signalling 1-based therapy in experimental abdominal aortic aneurysm. (2020) (3)
Nephroprotective Effects of Synthetic Flavonoid Hidrosmin in Experimental Diabetic Nephropathy (2021) (3)
Peptide Inhibitor of Nuclear Factor-kB Translocation Ameliorates Experimental Atherosclerosis (2013) (3)
PCSK9 and HS-CRP Predict Progression of Aortic Stenosis in Patients with Stable Coronary Artery Disease (2020) (3)
Expresión diferencial de proteínas en el corazón de ratas espontáneamente hipertensas con hipertrofia cardíaca (2005) (3)
Inflammatory biomarkers and statins. (2005) (3)
Monday, 27 August 2012 (2012) (3)
Fc (cid:1) Receptor Deficiency Confers Protection Against Atherosclerosis in Apolipoprotein E Knockout Mice (2006) (3)
Familial IgA nephropathy associated with bilateral sensorineural deafness. (1992) (3)
Disturbances of IgA immune regulation in lymphocytes from mucosae and peripheral blood in patients with IgA nephropathy. (1987) (3)
[New immunopathogenic aspects of IgA nephropathy]. (1990) (3)
Identification of novel biomarkers of abdominal aortic aneurysms by 2D-DIGE and MALDI-MS from AAA-thrombus-conditioned media. (2013) (3)
Statins in Hypertensive Patients: Potential Explanations for the ASCOT-LLA Study Results (2012) (2)
Soluble Fas ligand plasma levels are associated with forearm reactive hyperemia in subjects with coronary artery disease (2008) (2)
Immune abnormalities of IgA in six families with IgA nephropathy. (1987) (2)
Angiotensin II as a novel proinflammatory factor in chronic diseases (2009) (2)
Unraveling biomarkers of abdominal aortic aneurisms by iTRAQ analysis of depleted plasma. (2013) (2)
Interleukin-17A: Potential mediator and therapeutic target in hypertension. (2021) (2)
W01-P-004 The HMG-COA reductase inhibit oratorvastatin reduces FN14 expression induced by proinflammatory cytokines in human vascular smooth muscle cells (2005) (2)
[Statins, inflammation and atherosclerotic damage]. (2004) (2)
Activation of bombesin receptor Subtype-3 by [D-Tyr6,β-Ala11,Phe13,Nle14]bombesin6-14 increased glucose uptake and lipogenesis in human and rat adipocytes (2018) (2)
T-cell alterations in immunoglobulin A nephropathy. (1992) (2)
Unnecessary overuse. Study of "inadvisable practices" for patients with atrial fibrillation. (2017) (2)
Standard and novel therapeutic approaches to diabetic nephropathy (2015) (2)
Meta-Inflammation and De Novo Lipogenesis Markers Are Involved in Metabolic Associated Fatty Liver Disease Progression in BTBR ob/ob Mice (2022) (2)
EP 2 / EP 4 signalling inhibits monocyte chemoattractant protein-1 production induced by interleukin 1 b in synovial fibroblasts (2004) (2)
Atorvastatin reduces NF-κB activity and the expression of Interleukin-8, Metalloproteinase-3 and Cyclooxygenase-2 in a rabbit model of atherosclerosis (2000) (2)
Non-platelet-mediated vascular actions of 1-O-alkyl-2-acetyl-sn-3-glyceryl phosphorycholine (a synthetic PAF) (1981) (2)
Diabetes - experimental models (2013) (2)
[Vitamin D, metabolic syndrome and diabetes mellitus]. (2014) (2)
MCP-2/CCR8 AXIS IS ACTIVATED IN EXPERIMENTAL RENAL AND VASCULAR INFLAMMATION (2015) (2)
[Oligomeganephronia associated with congenital eye and skeletal abnormalities]. (1979) (2)
Delayed clearance of specific polymeric IgA immune complexes in patients with IgA nephropathy. (1983) (2)
Interleukin-17A: Possible mediator and therapeutic target in hypertension. (2021) (2)
Interaction of immune complexes with Fc receptors in mesangial cells: A potential target for the treatment of IgA nephropathy (1997) (2)
Acute renal failure in patient treated with anti-tumour necrosis factor alpha. (2011) (2)
24 HMG-CoA reductase inhibition by atorvastatin (ATV) induces apoptosis of vascular smooth muscle cells (VSMC) in culture—role of isoprenoids of the mevalonate pathway (1997) (2)
Differences between 2nd and 3rd generation seric parathormone determination methods on mortality in haemodialysis patients. (2017) (2)
P162Sitagliptin reduces fatty-acids uptake in detriment of glucose in experimental type-II diabetic hearts (2014) (1)
FP282FERROPTOSIS-MEDIATED CELL DEATH IS DECREASED BY CURCUMIN IN RENAL DAMAGE ASSOCIATED TO RHABDOMYOLYSIS (2019) (1)
FIBROBLAST GROWTH FACTOR 23 AND LOW 25 OH VITAMIN D PLASMA LEVELS ARE INDEPENDENT PREDICTORS OF CARDIOVASCULAR EVENTS IN PATIENTS WITH CHRONIC CORONARY ARTERY DISEASE (2013) (1)
Adverse effects of the renal accumulation of haem proteins. Novel therapeutic approaches (2018) (1)
Mechanisms and targets of glomerular damage (2012) (1)
PO18-510 OLIVE OIL AND WALNUT MEALS DECREASE THE INFLAMMATORY RESPONSE IN MONONUCLEAR CELLS DURING POSTPRANDIAL STATE IN HEALTHY MEN (2007) (1)
Urticaria-associated recurrent glomerulonephritis with a favorable response to indomethacin. (1992) (1)
cardiomyocyte hypertrophy play a key role in angiotensin II-induced Nox2-containing NADPH oxidase and Akt activation (2015) (1)
Renal delivery of adenovirus and antisense oligonucleotides in rats by retrograde renal vein injection. (2012) (1)
CKD GENERAL AND CLINICAL EPIDEMIOLOGY 1 (2014) (1)
Original articleInterplay between HSP90 and Nrf2 pathways in diabetes-associated atherosclerosisInteracción entre las vías HSP90 y Nrf2 en la aterosclerosis asociada a diabetes (2017) (1)
Effects of disodium cromoglycate and antihistamines in acute serum sickness of rabbits. (1977) (1)
Rituximab-associated interstitial lung disease in fibrillary glomerulonephritis (2013) (1)
New Therapeutic Approach to IgA Mesangial Glomerulonephritis (Berger’s Disease) (1981) (1)
Detection of cross-reactive idiotypes in blood and kidneys of patients with IgA nephropathy. (1987) (1)
ERA-EDTA Immunonephrology working group. (2010) (1)
Bisphenol (A) uremic toxin to take into account in the Renal disease in Hemodialysis (2017) (1)
TLR4-mediated inflammation is a key pathogenic event leading to kidney damage and fibrosis in cyclosporine nephrotoxicity (2016) (1)
Sickle cell nephropathy. Clinical manifestations and new mechanisms involved in kidney injury. (2021) (1)
Histone lysine-crotonylation in acute kidney injury (2016) (1)
Use of TOF-SIMS in vascular biology. (2013) (1)
PO23-765 CIRCULATING HUMAN MONOCYTES ON THE ACUTE CORONARY SYNDROME EXPRESS A CHARACTERISTIC PROTEOMIC PROFILE: EFFECT OF ATORVASTATIN IN THE PROTEOMIC PROFILE (2007) (1)
N-Terminal Pro-Brain Natriuretic Peptide Plasma Levels Are Associated with Intermediate-Term Follow-Up Cancer in Coronary Patients (2021) (1)
We-P14:454 The chronic intake of a mediterranean diet enriched in virgin olive oil, decreases nuclear transcription factor kappaB activation in healthy men (2006) (1)
Interplay between hypercholesterolemia and inflammation in atherosclerosis: Translating experimental targets into clinical practice. (2018) (1)
[Atorvastatin inhibits the atherosclerotic lesion induced by tumor necrosis factor-like weak inducer of apoptosis in apolipoprotein E deficient mice]. (2015) (1)
Low levels of plasma vitamin d predict the development of adverse events in patients with chronic coronary artery disease and high levels of fibroblast growth factor-23 (2013) (1)
Identification and Chemical Characterization of Insoluble Contaminants in Hemodialysis Water Treatment (2018) (1)
Impacto de los niveles plasmáticos de pro-péptido natriurético tipo B aminoterminal, proteína quimiotáctica de monocitos-1 y galectina 3 en la capacidad predictiva de eventos de la escala clínica LIPID en la enfermedad coronaria estable (2015) (1)
Heymann nephritis of rats: is a vasopermeability mechanism really needed for immune complex deposition? (1979) (1)
NT-proBNP Levels Influence the Prognostic Value of Mineral Metabolism Biomarkers in Coronary Artery Disease (2022) (0)
Pathogenesis of glomerular haematuria World Journal of Nephrology (2015) (0)
Augmented NF-kB activation and fas-ligand expression in the shoulder of human carotid atherosclerotic plaques (2001) (0)
Th-P16:356 Atorvastatin diminished ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk. Atorvastatin on inflammatory markers (AIM) study (2006) (0)
SP050PARICALCITOL EXERTS ANTI-INFLAMMATORY EFFECTS IN EXPERIMENTAL MODELS OF RENAL DAMAGE BY THE MODULATION OF THE NON CANONICAL NF-κB PATHWAY (2015) (0)
Abstract 1370: Biochemical and Proteomic Approach to the Study of the Experimental Diabetic Myocardium (2009) (0)
Evidence ofan immediate hypersensitivity mechanism in systemic lupus erythematosus 313 BASOPHIL DEGRANULATION UTILISING SONICATED DNA (0)
Protein-10 IsHighly Expressed inRatswithExperimental Nephrosis (1996) (0)
Experimental models of CKD (2013) (0)
IgAglomerulonephrit is (Berger's disease): evidence ofhigh serumlevels ofpolymeric IgA (1980) (0)
Searching for biomarkers of aneurysmal disease (2009) (0)
MOLECULAR MECHANISMS INVOLVED IN CARDIAC DIABETES (2008) (0)
[Influence of glucagon and insulin in the metabolism of lipids in patients under hemodialysis and renal transplants]. (1977) (0)
TWEAK or FN14 insufficiency inhibits neointimal hyperplasia through reduction of CYCLIN/CDKS expression and impaired vascular smooth muscle cells proliferation (2018) (0)
Parathyroid hormone-related protein (PTHrP) is overexpressed in atherosclerotic plaques of hyperlipemic rabbits and increases monocyte chemoattractant protein-1 (MCP-1) in cultured vascular smooth muscle cells (VSMC). Modulation by simvastatin (2001) (0)
CKD-MBD II MP 516 KDIGO-RECOMMENDED PTH LEVEL ACCELERATES AORTIC CALCIFICATION IN PATIENTS NEW TO HEMODIALYSIS (2013) (0)
PO9-227 5-LO/LTA4-H PATHWAY AND LTB4 RECEPTORS ARE INCREASE IN PLAQUE OF PATIENTS WITH CAROTID ATHEROSCLEROSIS. ROLE OF LTB4 IN NFKB ACTIVATION (2007) (0)
MO003IMPLICATION OF INTERLEUKIN-17A, CYTOKINE OF TH17 RESPONSE, IN VASCULAR DAMAGE (2016) (0)
Impact of renal function on the prognostic value of mineral metabolism in patients with chronic ischaemic heart disease patients with chronic ischaemic heart disease (2022) (0)
Subject Index, Vol. 61, 1992 (1992) (0)
P0541KLOTHO IS INVOLVED IN EARLY AND LONG-TERM PROTECTION AGAINST RHABDOMYOLYSIS ASSOCIATED AKI (2020) (0)
TWEAK as a Biomarker (2011) (0)
[Vasoprotective effects of statins and angiotensin II blockers in atherothrombosis]. (2005) (0)
Regulation of Vascular and Renal Cells by Common Mediators in Health and Disease: Role of the Renin—Angiotensin System in the Pathophysiology of Hypertension and Cardiovascular Disease (2010) (0)
W09-P-006 The NF-KB inhibitor parthenolide modulates the inflammatory responses in experimental atherosclerosis (2005) (0)
W12-P-007 Soluble TNF-like weak inducer of apoptosis (TWEAK), as a possible marker of atherosclerosis (2005) (0)
Angiotensin ii causes epithelial mesenchymal transdifferentiation via activation of smad and mapk signaling pathways (2006) (0)
Differences between 2nd and 3rd generation seric parathormone determination methods on mortality in haemodialysis patients (2017) (0)
MP241HAEMOGLOBIN INDUCES PODOCYTE INJURY IN MICE AND HUMAN WITH PATHOLOGIES ASSOCIATED WITH MASSIVE INTRAVASCULAR HEMOLYSIS (2017) (0)
Expression and Cytotoxicity in Activated Human T Lymphocytes 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Decrease Fas Ligand (2003) (0)
ANGIOTENSIN II INCREASES PARATHYROID HORMONE-RELATED PROTEIN AND ITS RECEPTOR IN THE KIDNEY: P3.238 (2000) (0)
A 008 PRESENCE OF TISSUE FACTOR AND OTHER COMPONENTS OF ATHEROSCLEROSIS IN HUMAN AORTIC VALVE STENOSIS (2009) (0)
Proteinuria and serum vitamin E correlate with pulse wave velocity (PWV) in diabetic non-dialysis chronic kidney disease (CKD) patients (2013) (0)
P2749PCSK9 and HS-CRP are predictors of the progression of aortic stenosis in patients with stable coronary artery (2019) (0)
MP244TWEAK/FN14 MEDIATES SECONDARY CELL DEATH DURING AKI (2017) (0)
FP272MASSIVE INTRAVASCULAR HEMOLYMASSIVE INTRAVASCULAR HEMOLYSIS INDUCES ACUTE KIDNEY INJURY IN A NRF2-DEPENDENT WAY (2019) (0)
ISN Forefronts in Nephrology: Mesangial Cells and Extracellular Matrix. Erlangen-Nürnberg, Germany, June 9-12, 1991. (1992) (0)
FP016PARICALCITOL INHIBITED ALDOSTERONE-INDUCED PROINFLAMMATORY FACTORS BY MODULATING EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY IN CULTURED TUBULAR EPITHELIAL CELLS (2015) (0)
P0087TRAF3 MODULATION: A NOVEL MECHANISM OF THE ANTI-INFLAMMATORY EFFECTS OF VITAMIN D RECEPTOR AGONIST PARICALCITOL IN RENAL DISEASE (2020) (0)
FP520BISPHENOL A (BPA) SERUM LEVELS IN HEMODIALYSIS (HD) PATIENTS WITH TWO DIFFERENT MEMBRANES (2015) (0)
YI-817 TUMOR NECROSIS FACTOR-LIKE WEAK INDUCER OF APOPTOSIS (TWEAK) ENHANCES RENAL DAMAGE-INDUCED BY HYPERLIPIDEMIC DIET IN APOE KNOCKOUT MICE (2007) (0)
Abstract: P678 HEAT SHOCK PROTEIN 90 (HSP90) INHIBITORS ATTENUATE INFLAMATORY RESPONSES IN VITRO AND IN VIVO (2009) (0)
Hydrolysis of Extracellular Pyrophosphate increases in post-hemodialysis plasma (2018) (0)
Contents Vol. 121, 2012 (2013) (0)
SP048THE BET BROMODOMAIN INHIBITOR JQ1 DIMINISHED RENAL FIBROSIS (2016) (0)
The elevated NF-kB activity and MCP-1 expression in endothelial-injured arteries from hypercholesterolemic rabbits are prevented by quinapril (1996) (0)
3,4-DGE is cytotoxic and decreases HSP27/HSPB1 in podocytes (2013) (0)
CELLS INCUBATED IN VASCULOGENIC CONDITIONING MEDIUM DRAMATICALLY IMPROVE ISCHEMIA/REPERFUSION ACUTE KIDNEY INJURY IN MICE (2018) (0)
Identificacion of transthyretin and β4 thymosin as potential biomarkers in aucte coronary syndrome by two independent methods, 2-DE/DIGE and SELDI/TOF (2008) (0)
CTGF: A key factor in the initiation and progression of kidney injury (2009) (0)
CD74 IS EXPRESSED IN HUMAN ATHEROSCLEROTIC PLAQUES AND MODULATES THE INFLAMMATORY RESPONSE IN VASCULAR CELLS IN VITRO (2008) (0)
Interleukin-17A: Potential mediator and therapeutic target in hypertension. (2021) (0)
Inflammatory biomarkers and statins. (2005) (0)
RHOA/RHO-KINASE PATHWAY REGULATES ANGIOTENSIN II-INDUCED CONNECTIVE TISSUE GROWTH FACTOR. POTENTIAL MECHANISMS OF STATINS ON ANGII-INDUCED VASCULAR DAMAGE: P1.69 (2004) (0)
Perpetuation of Immune Nephritis Respiratory Burst : Potential Role in the Through an Fc Receptor-Dependent Induce Polymorphonuclear Cell Recruitment Pre-Existing Glomerular Immune Complexes (2003) (0)
P3788Interleukin-17A is involved in renal damage associated with arterial pressure changes (2018) (0)
Abstract 10852: Sitagliptin Reduces Myocardial Fibrosis and Hypertrophy, Enhances Ppard Activation and Improves Diastolic Function in Experimental Type-2 Diabetes. (2010) (0)
Role of Toll‐like receptor 4 in intravascular hemolysis‐mediated injury (2022) (0)
SP057ROLE OF THE NON-CANONICAL NOTCH LIGAND DLK1 IN EXPERIMENTAL RENAL DAMAGE (2016) (0)
PO9-223 TNF-LIKE INDUCER OF APOPTOSIS (TWEAK) INCREASES ATHEROSCLEROTIC LESION SIZE AND INFLAMMATION IN APOE KNOCKOUT MICE (2007) (0)
SP068DEFERASIROX DEPLETES BCL-XL AND PROMOTES IRON DEPLETION-DEPENDENT DEATH OF PROXIMAL TUBULAR CELLS (2016) (0)
MP477SUPPRESSOR OF CYTOKINE SIGNALING-BASED THERAPIES TO COMBAT OXIDATIVE STRESS IN DIABETIC KIDNEY DISEASE (2017) (0)
Gremlin, A Potential Urinary Biomarker of Anca-Associated Crescentic Glomerulonephritis (2019) (0)
SOCS1-based therapies mitigate vascular and renal oxidative stress in diabetic mice through STAT1-and PI3K-dependent mechanisms (2018) (0)
Renal diseases : Progress of clinical science in Spain (1996) (0)
Transplantation: clinical studies - A (2013) (0)
1P-0258 Atovastatin diminishes Fas ligand expression in atherosclerotic plaques and blood mononuclear cells of patients with carotid atherosclerosis (2003) (0)
Atorvastatin reduces Fas ligand expression in activated human T lymphocytes (2001) (0)
23 Atorvastatin reduces lesion size and macrophage content in a rabbit model of atherosclerosis, and atenuates NFκB activation and MCP-1 expression in cultured VSMC (1997) (0)
W13-O-001 FC receptor deficiency reduces macrophage accumulation and plaque formation in apoE knock-out mice (2005) (0)
PO17-479 LIPID CARTOGRAPHY OF ATHEROSCLEROTIC PLAQUE. USE OF CLUSTER TOF-SIMS MASS SPECTROMETRY AS A MOLECULAR IMAGING TOOL IN VASCULAR PATHOLOGY (2007) (0)
Angiotensin IV activates nuclear transcription factor-kappa B (NF-$kappa;B) and activator protein-1 (AP-1) in vascular smooth muscle cells (1999) (0)
FP230VEGFR2 KINASE INHIBITION AGGRAVATES FOLIC ACID INDUCED ACUTE RENAL DAMAGE (2018) (0)
SP040BET BROMODOMAIN INHIBITION AMELIORATES EXPERIMENTAL INFLAMMATION IN THE KIDNEY (2016) (0)
2.P.72 Atorvastatin inhibition of NF-βB activation in vascular smooth muscle cells is mediated by protein isoprenylation blockade (1997) (0)
THU0118 Sequential ep1 and ep4 regulation in a rabbit model of antigen-induced arthritis (2001) (0)
Th-P17:441 Identification of soluble TNF-like weak inducer of apoptosis (STWEAK) by SELDI TOF-MS proteinchip system as a possible biomarker of atherosclerosis (2006) (0)
Immunological studies of experimental IgA nephropathy in mice. (1987) (0)
immune complex nephritis (1995) (0)
MP721A DECREASE IN INTACT PARATHYROID HORMONE (iPTH) LEVELS IS ASSOCIATED WITH HIGHER MORTALITY (2017) (0)
Translational Nephrology Lipids and renal cystic disease (2010) (0)
Th-P16:413 Atorvastatin decreased criculating CD40 ligand levels in subjects at highe cardiovascular risk Atorvastatin on inflammatory markers (aim) study (2006) (0)
Synthesisand Monocyte Chemoattractant Protein-1 B Activation k Nephritis Through Nuclear Factor-Recruitment in Experimental Immune Complex Angiotensin II Participates in Mononuclear Cell (1998) (0)
Experimental Study on Long-Term Exposure to a Biocompatible, Hypertonic, Pyruvate-Buffered Dialysis Solution R. van Westrhenen, A. Vlijm, J.K. Hiralall, and R.T. Krediet Disclosures: None (2009) (0)
ApoA-1 is oxidized in abdominal aortic aneurysm and promotes dysfunctional HDLs (2018) (0)
Reduction in the Risk of Peripheral Neuropathy and Lower Decrease in Kidney Function with Metformin, Linagliptin or Their Fixed-Dose Combination Compared to Placebo in Prediabetes: A Randomized Controlled Trial (2023) (0)
P6272Implication of Interleukin-17A, cytokine of Th17 response, in vascular damage (2017) (0)
W12.291 Butter and walnuts, but not olive oil intake, elicit nuclear factor-κB postprandial activation in peripheral blood mononuclear cells from healthy volunteers (2004) (0)
SP491DIFERENCIES IN BISPHENOL A (BPA) SERUM LEVELS IN ONLINE HEMODIAFILTRATION HEMODIALYSIS (HDF) PATIENTS WITH TWO DIFFERENT MEMBRANES (2017) (0)
[Pathogenic factors in diabetic nephropathy. Where do we come from and where are we headed?]. (2001) (0)
Postprandial lipemia activates NF-KB in peripheral blood mononuclear cells of healthy volunteers. Protective effect of red wine intake. (2001) (0)
Ccn2 deletion predisposes to aortic aneurysm formation and death in mice which is partially reduced by mineralocorticoid receptor antagonist treatment (2021) (0)
Tu-P7:246 Protective role of HSP27 in atherosclerosis (2006) (0)
Tubular overexpression of gremlin in transgenic mice aggravates renal damage in diabetic nephropathy (2015) (0)
Prevalence of fabry disease in malepatients with chronic renal disease not receiving renal replacement therapy: Preliminary report of a multicenter study (2007) (0)
Galectin-3 predicts cardiovascular events in patients with type-2 diabetes (2020) (0)
Curcumin treatment decreases acute kidney injury associated with rhabdomyolysis (2018) (0)
Literature abstracts (2001) (0)
B and T cell abnormalities in a large population of patients with IgA nephropathy (1990) (0)
The Synthetic Flavonoid Hidrosmin Improves Endothelial Dysfunction and Atherosclerotic Lesions in Diabetic Mice (2022) (0)
P360TWEAK or Fn14 insufficiency inhibits neointimal hyperplasia through reduction of Cyclin/CDKs expression and impaired vascular smooth muscle cells proliferation (2018) (0)
collagen production in cultured mesangial cells II-induced connective tissue growth factor and type IV on angiotensin β Inhibitory effect of interleukin-1 (2013) (0)
P-2 DE NOVO LIPOGENESIS MARKERS ARE INVOLVED IN METABOLIC ASSOCIATED FATTY LIVER DISEASE PROGRESSION IN BTBR OB/OB MICE (2023) (0)
CKD PATHOPHYSIOLOGY AND CLINICAL STUDIES (2014) (0)
4P-1176 Circulating FAS ligand levels are decreased in patients with combined hyperlipidemia and are normalized by atovastatin (2003) (0)
Immunological Aspects of Renal Vascular Involvement (1981) (0)
FC 087MIR-155/SOCS1 REGULATORY LOOP INFLUENCES DIABETIC KIDNEY DISEASE BY JAK/STAT PATHWAY MODULATION (2021) (0)
Atorvastatin and simvastatin interfere with NF-κB pathway activation elicited by reactive oxygen species in vascular smooth muscle cells and monocytes through a decrease in IκB-α phosphorylation (2000) (0)
Abstract: P679 INHIBITION OF TRANSCRIPTION FACTOR TRANSLOCATION WITH SYNTHETIC PEPTIDES REDUCES ATHEROSCLEROTIC LESIONS IN MICE (2009) (0)
W13.319 Moderate alcohol intake decreases nuclear factor kappa-B activation and circulating MCP-1 levels in healthy volunteers during a hyperlipidemic diet (2004) (0)
[Segmental renal hypoplasia and arterial hypertension. Study of 8 cases]. (1979) (0)
Identificacion of differentially expressed proteins in acute coronary syndromes (2009) (0)
Clinical and Population Studies Identification of Peroxiredoxin-1 as a Novel Biomarker of Abdominal Aortic Aneurysm (2011) (0)
Fibroblast Growth Factor 23 is a strong independent marker of worse cardiovascular outcomes after an acute coronary syndrome (2023) (0)
Correction: Mas, S., et al. Identification and Chemical Characterization of Insoluble Contaminants in Hemodialysis Water Treatment. Water 2018, 10, 486 (2018) (0)
High parathormone levels are associated with adverse cardiovascular events in coronary patients with high fibroblast growth factor-23 (2020) (0)
A proteomic approach to the myocardium of hypertensive-diabetic rats (2009) (0)
W04-P-006 HMG-COA reductase inhibitors, via Rhoproteins, decrease angiotensin H-induced connective tissue growth factor in vascular smooth muscle cells (2005) (0)
HCN4 AND GATA5 PREVIOUSLY UNDESCRIBED VARIANTS IN A LARGE KINDRED WITH FAMILIAL ATRIAL FIBRILLATION (2018) (0)
INTERLEUKIN-1BETA INHIBITS CONNECTIVE TISSUE GROWTH FACTOR AND FIBRONECTIN PRODUCTION CAUSED BY ANGIOTENSIN II IN MESANGIAL CELLS: P1.80 (2004) (0)
Implementation of proteomic biomarkers: making it work PERSPECTIVE (2012) (0)
Full Review Vitamin D receptor activation and cardiovascular disease (2012) (0)
P6433Coronary artery ectasia is a strong predictor of acute atherotrombotic events after an acute coronary syndrome (2018) (0)
SP425OXIDATION MARKERS AND BISPHENOL A (BPA) SERUM LEVELS RELATIONSHIP IN HEMODIALYSIS (HD) PATIENTS (2015) (0)
EXPERIMENTAL STUDIES HMG-CoA Reductase Inhibition by Atorvastatin Reduces Neointimal Inﬂammation in a Rabbit Model of Atherosclerosis (2016) (0)
analysisusing cDNA representational difference Heterogeneity of gene expression in human atheroma (2015) (0)
[The participation of platelet-activating factor and cytokines in the pathogenesis of glomerular damage]. (1990) (0)
MP687ALKALOSIS AND DIALYTIC CLEARANCE OF PHOSPHATE INCREASESPHOSPHATASE ACTIVITY: A HIDDEN CONSEQUENCE OF HEMODIALYSIS (2017) (0)
Correction for Martin-Sanchez et al., TWEAK and RIPK1 mediate a second wave of cell death during AKI (2018) (0)
Release of PAF and oxygen radicals by human neutrophils and rat mesangial cells stimulated with IgA and IgG immune aggregates (1990) (0)
PATIENTS WITH CORONARY DISEASE WITHOUT TRADITIONAL RISK FACTORS SHOW A MORE FAVORABLE PROFILE OF BIOMARKERS RELATED TO MINERAL METABOLISM, INFLAMMATION AND HEART FAILURE (2014) (0)
Important abnormalities of bone mineral metabolism are present in patients with coronary artery disease with mild decrease of estimated glomerular filtration rate Short title: CKD-MBD in coronary artery disease patients (2016) (0)
Role of NF-AT Pathway Activation of Renin-Angiotensin System : The Immune Complex Disease Is Linked to Local Susceptibility to T Cell-Mediated Injury in Okumura (2002) (0)
A009 Importance of tweak-CD163 system in peripheral artery disease (2009) (0)
Correction: Tubular Overexpression of Gremlin Induces Renal Damage Susceptibility in Mice (2014) (0)
Regulation of the IgA immune response in peripheral blood and in tonsillar lymphocytes from patients with IgA nephropathy. (1987) (0)
FP231TREATMENT WITH CURCUMINE DECREASES RENAL DAMAGE ASSOCIATED WITH RHABDOMYOLYSIS - ACUTE KIDNEY INJURY (2018) (0)
Organ-protection by an a 1-blocker plus an angiotensin converting enzyme inhibitor in hypertensive rats (2004) (0)
Tu-P7:197 Suppressors of cytokine signaling (SOCS) are expressed in atherosclerotic lesions and regulate JAK-STAT pathway in vascular cells (2006) (0)
PO19-564 INFLUENCE OF HIGH-DENSITY LIPOPROTEIN ON INFLAMMATORY MARKERS CONCENTRATIONS IN SUBJECTS AT HIGH CARDIOVASCULAR RISK (2007) (0)
ENDOTHELIAL PATHOPHYSIOLOGY FO024 GREMLIN REGULATES RENAL INFLAMMATION VIA VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 PATHWAY (2015) (0)
Modifications in the proteome of hearts from spontaneously hypertensive rats (SHR) treated with antihypertensive drugs (2004) (0)
[Angiotensin II : a key peptide in vascular and renal failure]. (2003) (0)
FO024GREMLIN REGULATES RENAL INFLAMMATION VIA VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 PATHWAY (2015) (0)
Novel Mediators of Ang II – Induced Fibrosis (2001) (0)
Justo, P. et al. Cytokine cooperation in renal tubular cell injury: the role of TWEAK. Kidney Int. 70, 1750-1758 (2006) (0)
P0525ROLE OF NADPH OXIDASE 4 IN ACUTE KIDNEY INJURY ASSOCIATED TO MASSIVE INTRAVASCULAR HEMOLYSIS (2020) (0)
Soluble TWEAK as a predictor of atheromatosis progression in patients with chronic kidney disease (2018) (0)
The role of PAF in kidney immune disorders (1987) (0)
Abstracts (2008) (0)
P3113Functional deficiency in activating fcgamma receptor protects against aortic abdominal aneurysm in mice (2019) (0)
MP094BISPHENOL A IS A UREMIC TOXIN THAT PROMOTES MITOCHONDRIAL INJURY AND DEATH IN TUBULAR CELLS (2017) (0)
N-terminal Pro-brain Natriuretic Peptide plasma levels are Associated With a Short-Term Diagnosis of Cancer in Patients with Coronary Artery Disease (2020) (0)
PROTEASOMES ARE THE TARGET OF ANGIOTENSIN II INHIBITION THERAPY (2002) (0)
SP377CIRCULATING BRANCHED CHAIN AMINO ACIDS ARE ASSOCIATED WITH LOW GRADE INFLAMMATION IN TYPE 2 DIABETES (2016) (0)
8 Immunoinflammation in Diabetic Nephropathy : Molecular Mechanisms and Therapeutic Options (2017) (0)
Therapeutic inhibition of HSP90 in a mouse model of diabetic atherosclerosis and nephropathy (2015) (0)
Pathogenic mechanisms of glomerulonephritis: apoptotic cell death. (2000) (0)
CELL SIGNALLING AND APOPTOSIS (2014) (0)
Absence of High Lipoprotein(a) Levels Is an Independent Predictor of Acute Myocardial Infarction without Coronary Lesions (2023) (0)
IgA immune aggregates stimulate platelet-activating factor and superoxide anion production by human neutrophils. A comparison with IgG aggregates (1991) (0)
Abstract 5511: Leukotriene B4 Enhances the Activity of NF-{kappa}B Pathway through BLT1 and BLT2 Receptors in Atherosclerosis (2008) (0)
Contents Vol. 38, 2014 (2015) (0)
Targeting metabolic disturbance in the diabetic (2015) (0)
Disturbances of IgA immune response in patients with ankylosing spondylitis (1990) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With J. A. Perea Egido?

J. A. Perea Egido is affiliated with the following schools:

J. A. Perea Egido's Academic­Influence.com Rankings

Why Is J. A. Perea Egido Influential?

J. A. Perea Egido's Published Works

Published Works

What Schools Are Affiliated With J. A. Perea Egido?

J. A. Perea Egido's AcademicInfluence.com Rankings